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Part I
“Gli aspetti di cose per noi importantissime sono nascosti a causa della
loro semplicita´. I veri fondamenti di un’indagine non colpiscono affatto
l’uomo che la compie” Ludwig Josef Johann Wittgenstein
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Abstract
Many proteins in nature show a modular topology, because it
is possible to recognize functional modules responsible of dis-
tinguishable functions in the protein [1]. Voltage-gated can be
considered modular proteins [55]. The superfamily of voltage-
gated channels is composed of channels in which a pore-module
is in charge of generating an ion conductance across the cell
membrane, and other “sensor”-modules perceive different stim-
uli and transmit them to the pore, readjusting the conductance
in response to changes within the cell. The sensor module in
voltage-gated channels is the voltage sensing domain. It is com-
posed of four transmembrane segments and it is able to feel the
electrical properties of the membrane, such as changes in poten-
tial and, through a mechanical load applied by a short linker, to
affect the gating of the pore (i.e. opening or closure of the chan-
nel) [2, 3]. A more sophisticated regulation is possible thanks to
other modules fused to the same channel. Ligand-gated channels
usually exhibit a C-terminal domain exposed in the cytoplasm,
in contact with all the variable concentration of second messen-
gers, able to modulate the activity of the channel. In this group,
cyclic nucleotide-gated channels have a C-terminal domain, com-
posed of a binding domain (CNBD) that respond to difference
in concentration of cAMP or cGMP, and a C-linker region, con-
necting the CNBD to the pore. The CNBD acts as an allosteric
domain, and modulate the channel opening upon cAMP bind-
ing [4].The idea that these domains evolved independently before
fusing in a single protein, is strengthened by the fact that similar
3
domains are found in a large variety of proteins, that don’t be-
long to channels family. For example, recently, a new enzyme was
discovered, the voltage-sensing phosphatase (VSP) of Ciona in-
testinalis, whose voltage-sensor domain is fused to a phosphatase
[5]. The CNBD of the hyperpolarized cyclic nucleotide-activated
channels (HCN), has a conserved structure compared to that of
the cAMP-dependent protein kinases [6]. My PhD thesis ad-
dresses two different topics, but in both cases I investigated how
sensor-modules can give a sophisticated regulation of channel
gating. In the first part, I approached the problem about how
voltage-dependence originated in voltage-gated channels, in par-
ticular I obtained a voltage-gated K+ channel fusing two unre-
lated protein modules: the voltage sensing domain of Ci-VSP
[5] and the pore-channel PBCV-1 Kcv [7]. The fusion between
a voltage sensor and a potassium channel with a quasi-ohmic
behaviour generates a chimaeric protein called KvSynth1, an de-
layed outward rectifier potassium channel. KvSynth1 retains the
pore properties of Kcv (selectivity and filter gating) and the volt-
age dependence of the Ci-VSP (half activation potential, slope
factor, shift of activation curve due to mutations). Moreover,
the quality of the rectification is dependent on the length of the
linker between the two modules. This highlights a mechanic
role of the linker in transmitting the movement of the sensor to
the pore, and shows that electromechanical coupling can occur
without co-evolution of the two domains. In the second part,
the allosteric modulation of the cyclic nucleotide binding do-
main of HCN channels has been studied on the basis of our
findings in the crystal structure of the CNBD of the isoform
4 of HCN (hyperpolarized cyclic nucleotide-activated) channels.
HCN are the molecular determinant of the If current, respon-
sible of the autonomic regulation of the heart. In the structure
of HCN4 CNBD a putative binding site for cyclic nucleotides in
the C-linker region was found. Occupancy of this binding site
by the prokaryote second messenger c-di-GMP can completely
revert the effect of cAMP in the micromolar range. Docking a
4
large set of molecules in the binding pocket, another compound
was identified, (N’-biphenyl-2-yl-N-[1-(3-cyanobenzyl)piperidin-
4-yl]-N-(pyridin-3-ylmethyl)urea), able to give the same effect on
cAMP modulation. The effect of these molecules is restricted to
HCN4; this isoform selectivity underlies that, although the C-
terminus of the three isoforms is structured in a similar way, the
modulation can be different. Some different features of HCN1,
HCN2 and HCN4 were already analysed previously [8]. These
results highlight the presence of an second modulatory pathway
in HCN channels, indicate a potential drug binding site for heart
rate modulation and advance understanding of the mechanism
of efficacy of cAMP binding in HCN channels.
5
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1 STATE OF THE ART
1.1 Voltage-gated channels
Voltage-gated channels belong to a large family of ion chan-
nels with a crucial role in excitability, in maintaining the resting
membrane potential and in the initiation and propagation of the
nerve impulse [2]. The identification of the channels involved in
the last phenomenon started from the early observation that in
the axon the permeability to ion species is different when the
membrane is at “resting” or under “excitation”. In particular,
the ionic current in the axon has two major components, the
Na+ and the K+ conductances: when an action potential oc-
curs, a strong inward Na+ current depolarizes the membrane,
and ENa is the electromotive force. K
+ current is responsible to
set the membrane potential again to a negative value, near to EK
(Fig.1.1). These two currents account for the action potential,
they show distinguishable selectivity and separate kinetics, but
both of them are voltage-dependent. The proteins that develop
these currents, are Na+ and K+ voltage-gated channels [9].
Voltage-gated channels are a great example of how nature
can produce a sophisticated protein device from simple bricks.
Since these proteins use the membrane electric field to regulate
cell functions, they acquired a tool to sense voltage. Within this
large group, that includes Na+, K+, and also Ca2+ channels an
accessory domain, the voltage sensor (VSD), senses the changes
in the electrical field of the membrane and transmits the signal to
7
Figure 1.1: Representative scheme of an action potential. The
sequential opening of voltage-gated Na+ and K+ channels generates the
action potential. The Na+ inward current depolarizes the membrane, while
the K+ conductance re-establishes the negative resting membrane potential.
the pore, affecting the open probability of the channel (Fig.1.2).
The voltage sensor, that controls this mechanism, is struc-
turally conserved among these specialized proteins: it contains
four transmembrane segments (S1-S4), in which the S4 is re-
sponsible of sensing electrical changes through a pattern of four
arginines placed every third position along the α-helix [10–12].
1.1.1 Mechanism of voltage sensing
The effect of voltage sensor on the pore gating is well-understood
in voltage-gated K+ channels, and, more in particular, in Shaker,
a eukaryotic Kv channel isolated from Drosophila melanogaster
(Fig.1.4) [13–17]. Pore opening occurs after the motion of the
VSD from a “resting” to an “active” state, and this conforma-
tional change is transmitted to the S5-S6 through the linker that
connects the two modules (Fig.1.3) [2].
The translocation of the S4-helix is due to a large amount
8
Figure 1.2: Basic architecture of voltage-gated channels. The car-
toons show the composition of Na+, K+, and Ca2+ channels. The segments
S1-S4 form the voltage sensing domain, while S5 and S6 organize the pore.
Na+ and Ca2+ channels are heterotetramers encoded by a single gene, while
K+ channels are composed of four identical subunits.
of positive charges that moves along five arginines residues of
the segment. The first consideration is that positive charges are
reorientated in response to a sudden change in the membrane
potential, looking for a new position at a low energy level. For
this reason, they generate fast transient currents, measurable in
9
Figure 1.3: Hypothetical transition close-to-open in Shaker. The
cartoon shows two subunits of a voltage-gated K+ channel. When the mem-
brane is depolarized the translation, rotation and tilting of the S4 segment
(blue) is transmitted through the S4-S5 linker, which is in contact with the
intracellular part of the S6 segment (magenta). In the closed position S6
is a straight alpha-helix, whereas in the open position it is bent, thereby
opening the gate. The dashed arrow represents ion conduction through the
open pore. The arginines are pictured in magenta.[2]
the absence of the ionic current by cut-open voltage clamp or
two-electrode voltage clapm. An example is reported in Fig.1.4
[18].
The kinetics and the voltage-dependence of this “gating” cur-
rent (represented by a Q-V curve) are a mirror of the behaviour
of the ionic current, since they are correlated with the opening
of the channel. Neutralization of many of these positive charges
by mutagenesis affects the open probability of the channel, giv-
ing a different effect on the ionic current that depends on the
contribution that aech of these aminoacids gives to the voltage
sensor movement [14].
In Shaker, the voltage dependence of the channel is very steep,
the open probability increases by a factor of 150 when ∆V is only
10mV. This corresponds to a large amount of charges moved in
the sensor region: in fact, measuring gating currents in a patch
where the number of expressed channels is known, it has been
determined that every channels moves 13 eo (electronic charge)
10
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[19]. If the charges move through each voltage sensor of a Shaker
channel, how does the pore integrate the motion of these inde-
pendent elements to move from a closed to a open conformation?
It has been demonstrated that a single wild type voltage sensor
is able to gate the pore of one channel, when the other three
sensor are mutated to neutralize all the basic charges [16]. The
property of this mutated channel, in which the composition of
the subunits is 1wt/3mut, is a left-shifted voltage dependence,
indicating that lower energy level is required to open the chan-
nel. In fact, the three mutated subunits are locked in the active
conformation, so that it is easy to move the channel in the open
state. In particular, transition states are one fourth of the wild
type, because each voltage sensor feels changes in the membrane
potential independently from the others, and only the last step
is cooperative, and leads to the final transition from the closed
to the open configuration [16].
1.1.2 Conformational changes in the voltage
sensor
Gating charges are a good marker of the conformational changes
occurring in the voltage sensor during the transition between the
resting and the active state. In voltage-gated channels is possible
to recognize common structural features, especially concerning
the voltage sensor. Many information were obtained from the
crystal structure of voltage-gated K+ channels solved by MacK-
innon and co-workers [20–23] (Fig.1.5) and from the structure of
a bacterial voltage-gated Na+ channel [24], but the movement
of the voltage sensor from the resting to the active state is still
debated.
The two most famous models are the “helical screw” or “slid-
ing helix” model and the “paddle” model. The first one assumes
12
Figure 1.5: X-ray structure of a chimera Kv1.2-2.1. The crystal
structure shows two subunit, in blue and in red. Voltage sensor is in the
activated conformation, pore is open. The structure reveal that S3 is com-
posed of two distinct helices, S3-S4. [2]
that the S4 moves outward of ∼ 13A˚ and rotate 180◦ to trans-
fer three charges per subunit, establishing new interactions with
negative charges in S2 segment [13, 25, 26]. The “paddle” model
is based on the observations arisen from the crystal structure
in the active relaxed conformation. The N-terminal part of S4,
together with part of the S3 (S3b), are involved in a large move-
ment from the more intracellular side to the extracellular, so that
they are free to move in the lipidic environment, with an exten-
sive traslocation [23]. The difference between this two models is
graphically summarized in Fig.1.6.
The absence of a structure in the resting state leaves a lot of
opened questions, although some electrophysiology results showed
that the “sliding helix” model can be supported. In Starace and
Bezanilla [28] the authors converted the voltage sensor of Shaker
in a proton pore, mutating the first and the second arginines
of S4 in hystidines. The voltage sensor behaves like a proton
pore, and this is possible only if the hystidines are in contact
with aqueous crevices (see Fig.1.7) on both sides of the mem-
brane. This behaviour can’t be reconciled with the “paddle”
13
Figure 1.6: Schematic representation of two models explaining
voltage-sensor movement. A: sliding helix model. The S4 moves out-
ward along its axis. B: paddle model. Red crosses indicate gating charges.
[27]
model, because the integrity of the protein/bilayer is not broken
by aqueous crevices in the structure.
For these reasons, a structure of the voltage sensor in the
resting position will be useful to understand the mechanism of
the traslocation. The more recent information about the resting
state are the results of long MD simulation [29]. These sim-
ulations show that S4 segment retains its helical conformation
as it moves principally along its axis, and the whole transition
comprises intermediate configurations, that may favor the non-
conductive closed state of the pore. This is consistent with the
X-ray structure of bacterial NaV channel [24] showing a closed
pore domain with voltage sensors in the activated conformation.
All these results fit with a model in which the first event of the
inactivation is the closure of the pore, followed by independent
inactivation of the VS [30]. Although MD can provide new evi-
dence of the transition of the voltage sensor, a structure of the
voltage sensor in the resting position will be useful to understand
the mechanism.
14
Figure 1.7: Sliding helix model is supported by proton-pore ex-
periments. Proton transport and conduction: models of the conforma-
tional changes of the voltage sensor. R362 and R365 are two arginine
residues of the S4 involved in gating charges movement. (a) Voltage de-
pendence of the gating-charge movement of the Shaker R365H channel. (b)
Voltage dependence of proton-transport current of the R365H channel. (c)
Voltage dependence of proton channel current of the R362H channel. (d)
Conformational changes during proton transport. In a proton gradient (in-
ward), the histidine at 365 (filled circle) transports one proton each time the
voltage sensor goes from the open to the closed conformation. (e) Repre-
sentation of the R362H channel proton pore. Internal and external protons
have simultaneous access to the histidine (filled circle) only in the closed
position, which results in a continuous proton current when the sensor is
closed. The protein core is grey. “Depo” and “hyper” indicate a more
positive and a more negative membrane potential, respectively. [28]
1.1.3 Modularity of voltage-gated channels
Voltage-gated channels represent a structurally conserved super-
family, in which we can easily recognize distinct functional mod-
ules, the voltage sensor and the pore domain. The demonstration
of the modularity of these proteins could suggest that Kv chan-
15
nels acquired the voltage dependence in one step, by fusion of
two independent modules. This hypothesis is now supported by
many evidence: (1) each modules, once detached from the orig-
inal channel, could be still functional, even if showing different
biophysical features [31, 32]; 2) the single domains that consti-
tute Kv channels can be found in different proteins. The voltage
sensing domain can be found also in the voltage-dependent phos-
phatase Ci-VSP isolated from Ciona intestinalis [5], or it can be-
come a proton pore as in Hv1 [33]; 3) the modularity should im-
ply that domains of different classes of channels can be swapped;
4) it should be possible to create a voltage-gated channel fusing
two unrelated protein domains. The literature offers some suc-
cessful examples about the evidence (1), (2) and (3); the results
obtained in (4) will be presented in the “Result” section of this
thesis. Concerning the functionality of isolated modules (1), it
has been shown that the prokaryotic voltage-gated K+ channel
KmLv maintained a functional conductive pore once the voltage
sensor is removed. The pore can be purified and reconstitution
in proteoliposomes generated a ohmic current, an expected be-
haviour of a pore that lack of the gating mechanism of the voltage
sensor [31]. Similar results were obtained from pore dissection
in a voltage-gated Na+ channel from Silicibacter pomeroyi [32].
Exemplary current traces recorded from the purified pore mod-
ule are shown in Fig1.8
Concerning the presence of the typical ion channels-modules
in enzymes (2), in 2005 Murata et al. published the charac-
terization of Ci-VSP, a phosphoinositide phosphatase regulated
by a voltage sensor, very conserved respect the one found in
voltage-gated channels. It is composed of four transmembrane
domains, and the S4 segment contains the conserved arginines
motif responsible of the translocation of the positive charges
generating the gating currents. In fact transient currents sim-
ilar to gating currents have been recorded from Ci-VSP, and
the derived Q-V curve showed a very right shifted and shal-
16
Figure 1.8: Pore dissection of (Na(V)Sp1) sodium channel. (A)
The pore of a bacterial voltage-gated channel has been isolated from the
voltage sensing domain. The pore module has been purified and recon-
stituted in proteoliposomes. (B) The pore generates a Na+ current when
inserted in the planar lipid bilayer. Representative single-channel traces.
[32]
lower voltage-dependence respect to ion channels (V1/2=+62mV,
z=1.03) (Fig.1.9). This can suggest that a smaller amount of
charges is moved upon depolarization [5]. The voltage sensor is
connected to a phosphatase through a linker, and the two mod-
ules are coupled thanks to this covalent connection: the VSD
motion rearranges the linker and turns on the phosphatase in the
activated conformation, stabilized by PI(4,5)P2 (phosphatidyli-
nositol 4,5- bisphosphate). The decreasing of the substrate de-
couples the VSD from the enzyme [34].
In the last years Ci-VSP has become a tool for understanding
the mechanism of the voltage-dependence, because the voltage
17
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sensor can be characterized independently from the influence of
a pore.
For example, it has been demonstrated that the VSD of Ci-VSP
shows a “mode-shift” behaviour, very similar to that already
studied in voltage-gated channels [35]. Mode-shift is a hysteresis
found in these channels: after prolonged depolarization, more
positive than +60 mV, the voltage sensors require stronger hy-
perpolarizations to return to their resting position. As a conse-
quence, the voltage dependence of the gating charges in the Q-V
curve shifts to more negative potentials compared with the Q-V
obtained when holding the resting potential at -90 mV [36]. The
physiological role of this mechanism is still not well-understood.
Kv channels are activated when the membrane potential is at
-50mV, after the onset of an action potential, and the mode-
shift prevents the closure or the recover from inactivation before
a resting of -70mV is reached again, avoiding too rapid firing
[36]. It still matter of debate if the mode-shift is due to a relax-
ation, and a conformational change of the voltage sensor, or if
it is due to an influence of the pore state (when it goes in the
inactivated conformation). The finding that Ci-VSP exhibits a
shift in the Q-V curve upon prolonged depolarization, seems to
confirm that mode-shift is an intrinsic property of the voltage-
sensor (Fig.1.10) [35].
The theory of the modularity implies that it should be pos-
sible to exchange modules between voltage-gated channels (3).
The literature offers many attempts of replacing the pore or the
voltage sensor of voltage-gated K+ channels, but, although the
results provided new interesting implications in understanding
the mechanism of coupling between the domains, it was possi-
ble to obtain functional chimeras only if the substitution con-
cerned small region of each module. The most famous exam-
ple of replacement has been reported by Lu et al. [37]: they
demonstrated that the pore domain is so conserved that Shaker
machinery can gate KcsA pore, maintaining the hallmarks of an
19
Figure 1.10: Shift of Q-V in Ci-VSP. (A) Family of sensing currents
of Ci-VSP (blue traces) in response to a series of test pulses (shown in black
below) ranging from -120 to 140mV from a holding potential of -60mV. (B)
Family of sensing currents for the same oocyte (red traces) for a series of
test pulses (shown in black below) ranging from -120 to 100 mV with a
5s conditioning prepulse to +80 mV precedes each pulse. (C) Relationship
between total charge movement and test pulse amplitude (QaˆV curves) from
an initial potential, Vi -60 mV (blue squares) and Vi +80 mV (red filled
circles). (Modified from [35]).
outward rectifier channel. The limitation is that the channel is
functional only if the C-terminus part of S5 and S6 remain un-
changed. In fact, when the whole pore of Shaker is replaced by
KcsA, the protein can reach the membrane but no detectable cur-
rent is measured [38]. This evidence revealed the importance of
the interactions between the S4-S5 linker region and the COOH
terminus of the S6, that are essential in the gating mechanism of
the channel [39], but it also underlined that eukaryotic voltage-
gated channels coevolved for long time, in a way that the two
20
modules became indivisible.
Figure 1.11: Replacement of the Shaker pore module with that
of KcsA. (A) Topology of the KcsA-Shaker chimaeric channel and par-
tial sequence of the parent channels around the splicing sites. (B) Current
recorded from KcsA-Shaker channel, and (C) activation curve obtained fit-
ting the data with Boltzmann equation. (Modified from [39]).
A similar strategy was used to demonstrate that it’s possi-
ble to exchange part of the voltage sensor of a voltage-gated
K+ channel, Kv2.1 [40], with the homolog sequences from the
prokaryotic channel KvAP, the voltage sensing phosphatase Ci-
VSP [5] and the proton channel Hv1. Many chimaeric constructs
were tested, and some of them are reported in Fig.1.12 but func-
tional voltage-gated channels were obtained only when the re-
placed sequence corresponds to the so-called paddle-motif [20],
including the S3b helix and the S4.
The authors concluded that the results pointed out that the
paddle motif is a modular unit common to different voltage sen-
sors, the only part that can be exchange between them, where
the voltage sensing mechanism resides.
21
Figure 1.12: Transfer of the voltage-sensor paddle motif from Hv1
or Ci-VSP into Kv2.1 channels. (a, b) Overview of chimeras between
Hv1 (a, light blue), Ci-VSP (b, dark blue) and Kv2.1 (black). Constructs
that result in functional Kv channel activity when expressed in oocytes are
indicated with green circles. The aminoacid alignment shows the sequence
of Kv2.1, Hv1 and Ci-VSP in S3 to S4, highlighting (blue bars) the stretch of
residues transferred to form the two chimeras indicated. (c) Current traces
and tail-current voltageaˆactivation relationships for a chimera expressed in
oocytes where the paddle of Ci-VSP was transferred into Kv2.1. (d) Current
traces and tail-current voltageaˆactivation relationships for a chimera where
the paddle of Hv1 was transferred into Kv2.1. (Modified from [40]).
22
2 AIMS OF THE PROJECT
2.1 Candidate domains for engineer-
ing a voltage-gated K+ channel
The aim of my PhD project was to take a step further in the
demonstration of the modularity of voltage-gated channels, ap-
proaching the problem from a different point of view, and answer-
ing the question: would it be possible to obtain a voltage-gated
channel fusing together two modules, a voltage sensing domain
and a pore domain, that are evolutionary unrelated? To create
this chimera we needed to find two candidates with an essen-
tial feature: they were supposed to be a sort of “rudimental”
proteins, providing the basic mechanisms of voltage-sensing (for
the VSD) and permeation (for the pore), and at the same time
operating independently. The ideal VSD was the one found in
Ci-VSP described in 1.1.3, in which the voltage sensor is linked
to a phosphatase. Although the two parts of the protein are
strongly coupled as it was recently demonstrated [41], the volt-
age sensor is still functional when detached from the enzyme, and
in particular, it maintains all its biophysical properties (voltage-
dependence, mode-shift,...) as shown in Fig.2.1 [35, 42]. Never-
theless, although this module shows high similarity with voltage
sensors found in ion channels, it was not known if it had been
able to gate a pore.
A good candidate to play the role of the pore in a voltage-
23
Figure 2.1: Shift of Q-V in Ci-VSP voltage sensor, after deletion
of the phosphatase. The voltage sensor without the phosphatase (Ci-
VSP with C terminus deletion from residue 244) also exhibits the Q-V shift
on initializing the protein with prolonged depolarizations to +80 mV. Fit
to single Boltzmann distributions showed V1/2 of +59mV and -41mV for
holding at-60 mV and conditioned to +80 mV, respectively. (Modified from
[35]
gated channel could be the viral K+ channel Kcv. Kcv is a small
channel, encoded by the genome of the giant virus PBCV-1. Its
94 aminoacids form two transmembrane domains, jointed by the
pore region that includes the canonical sequence of the selectivity
filter ofK+ channels [7]. Four indentical monomers are organized
in a tetrameric assembly (Fig.2.2[43]). Kcv lacks of regulatory
domains, it is not supposed to be regulated by external stimuli.
Because of its small size, it is a useful tool for understanding the
basic principles of protein assembly, ion conduction and gating
mechanisms.
Kcv is a robust and versatile channel, in fact it is heterolo-
gously expressed in Xenopus oocytes [7], in HEK cells [45] and
the purified protein can be reconstituted in a functional chan-
nel in artificial lipid bilayer [43] (Fig.2.3). The most important
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Figure 2.2: Putative model of Kcv from molecular dynamics. Two
subunits are shown. The selectivity filter is alternatively occupied by two
K+ ions and two water molecules. [44]
biophysical property, for our purpose, is the quasi-linear cur-
rent/voltage relationship, except for potentials more negative
than -100 mV, where a rectification occurs due to a channel
flickering at the level of the selectivity filter [44, 46]. This flick-
ering is responsible of the “fast gasting” at extreme potentials,
when the channel openings become exceedingly noisy because of
unresolved closures. This is due to ion depletion in the selectiv-
ity filter when voltage pulls ions more rapidly out of the filter
than they can be supplemented from the cytosol [44]. A second
mechanism is called ”slow gating”, and it is related to very low
open probability of Kcv, that spends most of the time in the
closed state. The short second transmembrane domain seems to
exclude the effect of a “bundle-crossing” similar to the one found
in KcsA [47], so this feature recapitulates again to the selectivity
filter [44].
From the electrophysiology characterization it is clear that
the elementary mechanisms of ion conduction and gating can
be performed by a single pore-module, as Kcv. The essential
structure and function features make Kcv a good module to add
new regulation. For this reason we tried to modify the properties
of voltage-dependence of this pore-module in one step, by fusion
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Figure 2.3: Kcv biophysical properties (A) Representative current
trace and I-V curve of Kcv expressed in Xenopus oocytes. Kcv currents are
developed instantaneously, the current-voltage relationship shows a quasi-
ohmic behaviour, the channel is open over a wide range of positive and
negative potentials. (B) Similar behaviour is observed in Kcv expressed in
HEK 293 cells. In the graph are plotted the I-V curves of both the instanta-
neous and the steady-state current [44]. (C) Single-channel recording from
lipid bilayer of the reconstituted protein Kcv in proteoliposomes [43].
of a domain usually in charge of this function in voltage-gated
channels.
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3 RESULTS
3.1 The fusion protein KvSynth1
To test if the pore-module Kcv can be gated by Ci-VSP ma-
chinery, we created a fusion protein in which the voltage sensor
of Ci-VSP (aminoacids 1-239) is directly connected to the N-
terminus cytosolic slide-helix of Kcv (aminoacids 1-94).
The construct was obtained by overlap-PCR and cloned into
BamHI and XhoI restriction sites of pSGEM vector (a modi-
fied version of pGEM-HE). T7-in vitro transcription system was
used to produce mRNA. The fusion protein and the individual
modules were expressed in Xenopus oocytes and the activity
measured by two-electrode voltage clamp. VSD-injected oocytes
do not show relevant currents, similar to water-injected oocytes,
because it has been shown that this voltage sensor is not able to
conduct any ionic current [5]. Kcv-injected oocytes generate the
previously characterized current (Section 6.1): the main evident
feature is the nearly-ohmic relationship of the current respect to
the voltage. The fusion protein, KvSynth1, encodes for a func-
tional channel, characterized by large currents compared to the
one of VSD-injected oocytes, and very different from Kcv: the ki-
netic shares similar features with voltage-gated channels [48], be-
cause depolarized potentials generates time-dependent outward
currents compared to the small remaining instantaneous com-
ponent. The voltage-current relationship confirms the strong
outward rectification of the chimera (Fig.3.1).
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Figure 3.1: KvSynth1 encodes for a voltage-gated channel. Panel A:
cartoons of the individual components and of the fusion protein KvSynth1.
Grey cartoon: the voltage-sensing domain (aa 1-239) of Ci-VSP; S1-S4 indi-
cate the 4 transmembrane domains. Orange cartoon: Kcv, viral K+ channel
(aa1-94) ; TM1, TM2 and P indicate respectively the two transmembrane
domains and the pore loop of Kcv. Panel B: Currents recorded by TE-
voltage clamp in oocytes injected with the three constructs. Dotted line
indicates zero current level. Voltage protocol: Vholding -20 mV, test volt-
ages +100 to -100 mV (-200 mV for Kcv), tail -80 mV. Test pulse length
is 8.5 s for KvSynth1 and VSD-injected and 0.6 s for Kcv-injected oocytes.
Panel C: corresponding steady-state I-V relationships of KvSynth1 and Kcv.
All experiments were performed in [K+] 50mM.
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3.1.1 KvSynth1: pore properties
In order to asses if each module is intrinsically capable to play
its specific role in the new chimera, we tested selectivity and per-
meability properties of KvSynth1. The data show that KvSynth1
is still potassium selective, because it has the same Nernstian
behaviour previously reported in Kcv (Fig.3.2); moreover, the
replacement of external K+ with an equivalent concentration of
Na+ shifts the reversal potential of the fully activated current
of about −80 ± 6mV, so that the permeability ratio PNa/PK is
0.05±0.01, very similar to the ratio measured in Kcv (0.03±0.01)
[7] (Fig.3.3).
Figure 3.2: Selectivity of KvSynth1. Nernst plot: KvSynth1 current re-
versal potential (Erev) plotted as a function of external K
+ concentration
(Log[K]out) corresponding to 20, 50, 100mM. Black line is the linear regres-
sion to mean Erev values (n=3). Slope factor is 58.5mV, very similar to the
K+ theoretical equilibrium potential [9].
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It’s important to notice that the typical behaviour observed
in the current-voltage relationship of Kcv is maintained in KvSynth1
during the full activation protocol (Fig.3.3). This protocol allows
to record the single-channel like behaviour because (vedi libro).
Figure 3.3: KvSynth1 selects K+ over Na+. Current reversal potential
recorded from the same oocyte was -20 mV in 50 mM [K+]out () and
-98 mV in 50 mM [Na+]out (). Voltage protocol: pre-pulse voltage step
at +60 mV followed by testing voltages from +60 to -180 mV. Arrowhead
marks the point of data collection.
The other Kcv properties that are preserved in KvSynth1 are
the blocking effect of Ba2+ on the inward component of the cur-
rent, and the stability of the tetrameric assembly of the protein
in SDS-PAGE. Infact, it has been previously reported that the
potassium current of Kcv is blocked in a voltage-dependent man-
ner by the divalent cation Ba2+ with a KD of 1µM. In particular
Ba2+ ions at the concentration of 1mM can completely remove
the inward current measured at steady-state: the same effect has
been recorded in oocytes expressing KvSynth1, when the external
potassium solution is supplemented with 1mM BaCl2.
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Figure 3.4: Effect of Barium on KvSynth1 current. Steady-state
currents recorded in: () control solution (50 mM [K+]out) and () +1mM
BaCl2. The addition of barium blocks the inward current and affects the
outward current, as previously reported for native Kcv channel [7].
We also tested the pore mutation F305A that, as expected
from our previous results with the Kcv mutant F66A ([7]), com-
pletely abolished the current in KvSynth1 (See Fig.3.7). This
result confirms that the current recorded in KvSynth1-injected
oocytes can not be considered an endogenous current. The pu-
rified protein Kcv is recognized in its tetrameric form in SDS-
PAGE by the monoclonal antibody 8D6. Previous experiments
of size exclusion chromatography demonstrated that a single
molecule of antibody form a complex with a tetramer of pu-
rified Kcv (expressed and purified in Pichia pastoris [43]. This
monoclonal antibody has been used to recognize the tetrameric
form of the chimera KvSynth1, detecting it by western blot on
crude lysate of oocytes expressing the channel.
The antibody is able to recognize both Kcv and KvSynth1, and
this result highlights that the pore structure is reasonably still
conserved and the chimera has a quaternary assembly that al-
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lows the formation of a tetramer. Infact it’s worth noting that
Ci-VSP performs its function in the membrane as a monomer,as
demonstrated by TIRF (total internal reflection fluorescent) mi-
croscopy experiments [49], but in our case, Kcv pore drives the
arrangement of the protein structure.
Figure 3.5: Western blot analysis performed total protein extract from
oocytes with a monoclonal antibody (8D6) that recognizes the tetramer
of Kcv, but not the monomer. The expected MW of Kcv and KvSynth1
tetramers are 42,5 and 149 kDa, respectively. H2O injected oocytes lysate
is loaded for control.
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3.1.2 KvSynth1: voltage sensor control
The contribution of the voltage sensor of Ci-VSP to the voltage
dependence of KvSynth1 is translated in a modified open prob-
ability of the channel respect to Kcv: the voltage sensor closes
the pore at negative voltages and slowly opens it at depolarizing
potentials. Tail currents recorded at -80mV with the same pro-
tocol in Fig.3.1 were plotted against applied voltages and fitted
with a Boltzmann distribution
y =
1
1 + e
zF (V−V 1
2
)
RT
where z, F, R, T have their usual thermodynamic meaning,
and the instantaneous current was subtracted. The graph repre-
sented in Fig.3.6 shows that KvSynth1 has a half-activation poten-
tial of +56mV and a z value of ∼1; the very positive activation
potential and the shallow voltage dependence strongly resemble
the slow and shifted behaviour of ’sensing’ currents measured in
Ci-VSP respect to voltage-gated K+ channel (Fig.1.9). The volt-
age sensor closes the channel at negative potentials and opens
it with a slow kinetics at voltages more positive than zero mV
(t1/2=450± 74 ms at +60 mV (n=4 oocytes)).
To demonstrate that the voltage sensor exerts a tight control
on the pore, and that the potassium current developed by the
channel is the direct effect of the state in which the voltage sensor
is, we reproduce specific mutations in the voltage sensor whose
phenotype has been previously characterized in Ci-VSP. The first
mutation is the R229Q/R232Q in the fourth subunit of the VS:
these aminoacidic positions consist of two positive arginines re-
sponsible of the traslocation of the charges along the α-helix, and
their neutralization in Ci-VSP leads to a functional phosphatase,
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Figure 3.6: Voltage dependency of KvSynth1. (B) Activation curve of
KvSynth1 constructed from tail currents (A) after subtracting the instanta-
neous current offset. Voltage protocol as in Fig.3.1. Data sets (n=6) were
jointly fitted to a two-state Boltzmann equation. V1/2=56 mV, z=0.92.
localized in the oocyte membrane, but insensitive to potential.
Infact, when the mutations are placed in KvSynth1, we obtained
a channel almost closed, with a quasi-Ohmic I/V relationship.
The voltage sensor seems to be blocked in a conformation that
is not more useful to open and regulate the pore. In a simi-
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lar way Shaker conductance is affected when these arginines are
replaced by neutral or negative charged aminoacids [50], suggest-
ing that well-established mechanisms can be easily reproduced
in this bona fide channel.
Figure 3.7: Steady state current/voltage relationships of the single mutant
F305A (), the double mutant R229Q/R232Q () and the wt KvSynth1
(). Points represent mean±(s.e.m) (n=6).Currents were recorded from
a Vholding of -20 mV. Test pulse is 600ms for KvSynth1 wild-type and
R229Q/R232Q. The low level of expression of the R229Q/R232Q mutant
does not allow to apply long test pulses, due to endogenous current contam-
ination that develops upon long depolarization.
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Voltage sensor control is so effective that it is possible to af-
fect the voltage dependence of KvSynth1 mutating the arginine
in position 217 (R217Q). This aminoacid does not contribute to
gating charges [51], but probably interacts with a part of the
voltage sensor that undergoes to a conformational change upon
potential stimulus, and the effect of the mutation is a left shift of
the Q-V curve to a value of ∼ 12mV [35]. KvSynth1 R217Q gen-
erates a channel with a G-V curve that matches with “sensing”
charges curve (V1/2=17.9±0.3 mV). In figure 3.8 the G-V curves
of both the wild-type and the mutant are plotted for comparison.
Figure 3.8: Activation curve of the R217Q mutant. The activation
curve of the mutant () has been constructed as in Fig.3.6 (n=4). The
activation curve of the wild-type is re-plotted for comparison (black line).
V1/2=18 mV, z=1.1.
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As shown by the current traces and the I-V curve in Fig.3.9
(obtained by averaging n=3 oocytes with comparable levels of
current for KvSynth1 and KvSynth1 R217Q) the mutated channel
opens early respect to the wild-type, so that it has a more rele-
vant inward current.
We used this mutant also to turn out the presence and, even-
tually, the influence of the relaxed state of the Ci-VSP voltage
sensor on the Kcv pore. S4 enters in a relaxed state trough a
conformational change, in which the α-helix turns into a 310helix,
reaching a lower and more stable energy state, when the chan-
nel is stimulated for long time with depolarizing potentials. The
effect of the relaxation is that the center point of the Q-V curve
depends on the value and the duration of the holding potential.
In voltage-gated channels this hysteresis has been for long time
correlated to the development of slow inactivation, explained as
a mechanical load that is imposed upon the voltage sensor by
the pore domain [36]. But in the last years, it has been demon-
strated that the voltage sensor of Ci-VSP also exhibit the typical
“mode-shift” behaviour, with a left shift of the Q-V curve upon
a prolonged depolarization at +80mV [35]. What could be the
effect of this relaxation of the VS on Kcv pore? And, if an effect
is observed, is it similar to the one found in voltage-gated chan-
nels? To investigate this, we recorded the current of KvSynth1
R217Q applying a 5 seconds preconditioning pulse at -100mV or
at +40mV, that represent respectively the potentials in which
the voltage sensor is in the resting and in the active state. We
took advantage of this mutant because the left shift of the G-V
curve allowed us to pre-conditiong at a value of +40mV. More
positive prolonged pulses can stimulate endogenous current in
oocytes, affecting the results. What we observed with this pro-
tocol is shown in Fig.3.10: when the voltage sensor is initialized
with a depolarizing pulse, the V1/2 of the G-V curve settles to
a more negative value, and this can be interpreted as an early
opening of the channel, once the voltage sensor reached the lower
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Figure 3.9: KvSynth1 R217Q. Representative current traces and I-V
curve of KvSynth1 R217Q compared to the wild-type construct. The I-V
curves show that the mutant ( ) has a more prominent inward component
of the current respect to the wild-type ( ). The I-V curves are obtained
from average of oocytes with similar level of current expression (n≥ 3).
energy state. The two G-V curves plotted in Fig.3.10 go in the
same direction of the Q-V curves of ’sensing’ charges published
in [35], but the value of the shift can be considered just qual-
itatively because the curves don’t represent the full activation
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of the channel: test pulses are shorter (1.2 seconds instead 10
seconds), to maintain the effect of the preconditioning voltages.
Figure 3.10: The activation of the R217Q mutant depends on
the pre-conditioning voltage. The same R217Q expressing oocyte was
subjected to the following protocol: pre-conditioning (5 s) at either -100 mV
or + 40 mV; test pulses (1.2 s) from -120 mV to +30 mV. Tail currents (at
-80 mV) are plotted for pre-conditioning at -100 mV () or at + 40 mV ().
The test pulses were kept short to maintain the effect of the preconditioning
voltages; hence data do not reflect full activation of the channel.
All these results outline that the voltage sensor of Ci-VSP
can control the pore opening, and, in particular, the proper-
ties of this independent module, i.e. the conformational changes
that it undergoes, directly affect the development of the current
through the pore. The effect of the mutations on KvSynth1 de-
scribed above, demonstrates that the channel behaves in a spec-
ular way respect how “sensing” charges feel the electrical field
across the membrane. This suggests a simple but surprisingly
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coupling between the two modules.
3.2 The relevance of the linker in KvSynth
constructs.
In KvSynth1 the slide-helix of Kcv is the only covalent linker be-
tween the pore and the voltage sensor, so it is presumable to
hypothesize that this is the crucial point in which the coupling
is established. Does KvSynth1 require a specific linker composi-
tion, or structure, or length? To assess if the linker plays a key
role in the synthetic channel, we produced constructs in which
the voltage sensor of Ci-VSP (aa1-239) is connected to Kcv com-
bining in a different way the N-terminus of Kcv (aa 1-12) and
the linker of Ci-VSP (aa 239-255) (see Fig.3.11).
Except for the construct KvSynth1.5, with a long linker of 28
aminoacids, all the other constructs express functional channels
with large potassium currents. As it is shown by the more repre-
sentative traces (Fig.3.12) every channel has different kinetic and
fraction of the inward current respect to the total amount. Any-
way, a dramatic change can be observed in KvSynth0.2, a chimera
that strongly resembles Kcv, showing the rectification of the cur-
rent at extreme negative potentials.
The same behaviour can be observed plotting the I-V curves
of the chimeras with a linker of 20, 12, 6 and 4 aminoacids
(Fig.3.13 A): the four channels show different level of inward
current, that can be interpreted as a various ability of the linker
to transduce the conformational change of the voltage sensor.
To quantify the degree of rectification of KvSynth constructs we
measured the ratio between the current recorded at +60mV and
at -100mV (I+60/I−100), exactly at the same distance from the
reversal potential in an external solution of KCl 50mM (for Kcv
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Figure 3.11: KvSynth constructs. Cartoon representation of the voltage
sensing domain of Ci-VSP and the pore Kcv. The sequences refer to the
linkers of the two modules, that were combined to create all the KvSynth
constructs. The table shows the linker composition: the color code is the
same of the cartoons.
wild-type I+60/I−100=1). The average ratios calculated for ≥ 3
oocytes of each construct were plotted against the length of the
linker and fitted with a logistic function, in which the lower
asymptote is set to a value of 1, that corresponds to a channel
with no rectification, as Kcv. The curve shows that the control of
the voltage sensor is achieved when the linker is kept shorter than
20 aminoacids, and the saturating effect is reached between 12
and 6 aminoacids. In this range the properties of KvSynth don’t
change too much, and a linker of 6 aminoacids represents the
extreme limit beyond which it is possible to observe an outward
rectifier behaviour. KvSynth0.2, in fact, regains the typical prop-
erties of Kcv: the pore is perfectly functional, but the linker is
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Figure 3.12: KvSynth constructs. Representative current traces of
KvSynth constructs. The figure shows the current recorded in the con-
structs with different linker length. The inward current component decreases
togheter with the linker lenght. KvSynth0.2, with a linker of 4 aminoacids,
regains the properties of Kcv. The current traces are normalized to the
value recorded at +60mV.
so short that probably the voltage sensor is screwed up and it
can not exert any kind of regulation.
The idea that the length of the linker is the predominant fea-
ture in determining the quality of the outward rectification is
supported by the fact that KvSynth1.4 and KvSynth1.3 have both a
linker of equal length but different aminocidic composition: the
degree of rectification is the same.
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Figure 3.13: Relationship between the linker length and the de-
gree of rectification in KvSynth constructs. Panel A: I-V curves from
KvSynth 1.4 (), 1 (), 0.1 () and 0.2 () with a linker of respectively 20,
12, 6 and 4 aminoacids. The current is normalized at +60mV. Panel B: The
degree of current rectification (I+60mV /I−100mV ) is plotted as a function of
linker length for all functional constructs. The degree of rectification of the
constructs in Panel A are represented with the same color code. Data are
mean±(s.e.m.). Experimental data (with the exclusion of the value corre-
sponding to the construct with a 4 aa linker that loses the rectification) have
been interpolated with a sigmoidal function (grey dashed line) in which the
lower asymptote was set to 1, corresponding to the value measured in Kcv
that lacks rectification (dotted line).
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3.3 Expression and purification of the
recombinant KvSynth1
In order to understand better the biophysical properties of the
synthetic channel, structural studies and single channel measure-
ments on the purified protein are required. The first step to ap-
proach a structural investigation is to express the protein in an
heterologous system, such as E. coli. The coding region of the
whole KvSynth1 channel (residues 1-333) was cloned into three
plasmids (pQE-32, pQE-70 and pGEX-6P-1) and each of them
was transformed into three different E. coli expression strains
(BL21(DE3), XL1-Blue and XL10-Gold).
A single colony for each strain was used for the initial expression
test.
The expression test was carried out at 37◦C using 1mM IPTG
(isopropyl-β-D-thiogalactopyranoside) as induction molecule. The
protocol used for the detection of the expressed protein is similar
to [52]. The table 3.3 summarizes the results got from this first
step.
Construct Affinity tag Vector Promoter E. coli strain Expression level
KvSynth1 N-term His tag pQE-70 T5 XL1-Blue -
C-term His tag pQE-70 T5 XL10-Gold -
C-term His tag pQE-70 T5 XL1-Blue -
C-term His tag pQE-70 T5 SG009 -
C-term His tag pQE-70 T5 M15 -
N-term His tag pQE-32 T5 XL1-Blue [+]
N-term His tag pQE-32 T5 XL10-Gold [++]
N-term His tag pQE-32 T5 SG009 [+]
N-term His tag pQE-32 T5 M15 +
N-term His tag pGEX-6P-1 LAC BL21* -
N-term His tag pGEX-6P-1 LAC XL1-Blue -
Table 3.1: E. coli Strains and Constructs for the Initial Expression
Test
Positive (+) and negative (-) signs indicate the relative expression level from
Western blot: -, no visible band of expression; +, visible band. Multiple
signs indicate relatively higher expression levels. The condition in brackets
was chosen for further expression optimization.
As a result of the first expression test, the only construct
that gave expression was the pQE-32::KvSynth1 in all the three
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tested E. coli strains (Table 3.3). In order to have a yield im-
provement, for the subsequent purification step, expression op-
timizations were set up at different temperatures and different
concentration of IPTG . Initially the temperature was decreased
to 30◦C and the IPTG was used at the concentration of both
1mM and 500µM . The expression was then monitored each hour
for three hours and the expression level was detected by wester
blot analysis (as described in [52]).
The best expression level at 30◦C was achieved by the E. coli
strain XL10-Gold. Further improvements were carried out only
on this strain.
Since the protein detected by western blot seems to be partially
degraded during the course of the three hours, two lower tem-
peratures (28◦C and 25◦C) were used in the next optimization
step.
Both 28◦C and 25◦C had no significant improvement in protein
expression. For large-scale expression, the following protocol was
adopted:
• Temperature: 30◦C
• OD600: 0.9
• IPTG concentration: 1mM
• Induction time: 3 hours
A preparative expression (1 L culture) of KvSynth1 was con-
ducted as described above. The cells were then harvested and
resuspendend in the breaking buffer (150mM NaCl, 20mM Tris-
Cl pH=8.0, 1mM PMSF, 0.1mg/ml DNAse, 5mM MgCl2, 1mM
EDTA, 0.125mg/ml lysozime and the inhibitor cocktail). The re-
suspension was incubated for 30min at 4◦C and then sonicated
12× 20sec. After an additional incubation on ice for 10min, the
sample was centrifuged at 100000xg for 30min at 4◦C.
The supernatant was discarded and the pellet was resuspended in
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10ml of resuspension buffer (100mM NaCl, 50mM KCl, 20mM
Tris-Cl pH=8.0 and 5mM MgCl2) as crude membranes. The
membrane suspension was, then, divided into twelve eppendorf
tubes and on each of them was added a different detergent (Ta-
ble 3.2) at 10 times their critical micelle concentration (except
for DM and OM that were added at 5.6x CMC and 2x CMC,
respectively). After three hours of solubilization at room tem-
perature, the samples were centrifuged at 100000xg for 1 hour
at 4◦C. The supernatant and the pellet (completely dissolved
in laemmli buffer in the same initial volume) were loaded onto
SDS-PAGE and subjected to Western-blot analysis to test the
solubilization efficiency.
Figure 3.14: Western-blot analysis of the screened detergents (see Ta-
ble 3.2). M: molecular weight marker (Fermentas); S: soluble fraction after
spinning the solubilized samples at 100000xg for 1h; P: pellet fraction re-
suspended in Laemmli buffer. The band corresponding to the monomeric
form of KvSynth1 has a 40kDa molecular weight.
Based on the results of the western-blot analysis (Fig. 3.3),
5 detergents of the 11 screened were able to solubilize the pro-
tein, although a substantial portion of it remains in their pellet
fraction. Of this five detergents, three were selected (LDAO,
UDM and OM) for the next solubilization improvement, com-
bining a higher detergent concentration (20xCMC) with a lower
solubilization temperature (4◦C). LDAO and UDM were chosen
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Detergent CMC (H2O) Used CMC
DDM 0.17mM 10x
n-Docecyl-β-D-Maltopyranoside
DM 1.8mM 5.6x
n-Decyl-β-D-Maltopyranoside
TDM 0.033mM 10x
n-Tridecyl-β-D-Maltopyranoside
UDM 0.59mM 10x
n-Undecyl-β-D-Maltopyranoside
OM 19.5mM 2x
n-Octyl-β-D-Maltopyranoside
LDAO 1-2mM 10x
n-Docecyl-N,N-Dimethylamine-N-Oxide
OG 18-20mM 10x
n-Octyl-β-D-Glucopyranoside
DDG 0.19mM 10x
n-Dodecyl-β-D-Glucopyranoside
NG 6.5mM 10x
n-Nonyl-β-D-Glucopyranoside
DG 2.2mM 10x
n-Decyl-β-D-Glucopyranoside
Triton X-100 0.23mM 10x
Octylphenol Ethylene Oxide
CHAPS* 8-10mM 10x
Table 3.2: Detergents used in the solubilization screen.
* CHAPS is an abbreviation for 3-[(3-cholamidopropyl)dimethylammonio]-
1-propanesulfonate
for their higher ratio “solubilized: not-solubilized”, OM was, in-
stead, selected because in the original solubilization screening it
was used at a concentration of 2xCMC and the improvement was
then carried out at 10xCMC. The new solubilization screening
was prepared as discussed above and the samples were subjected
to Western-blot analysis. The results are reported in Fig. 3.15.
As the western-blot shows, the best results are achieved at 4◦C
with both UDM (20xCMC) and LDAO (10xCMC). Moreover
LDAO appears to be able to solubilize more than 90% of the
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protein, so it will be used in the subsequent purification steps.
Figure 3.15: Western-blot analysis of the screened detergents (see
Table 3.2). M: molecular weight marker (Fermentas); S: soluble fraction
after spinning the solubilized samples at 100000xg for 1h; P: pellet fraction
resuspended in Laemmli buffer.
For purification purpose, 4L of colture medium were inducted
and prepared as described above. The cells were harvested and
resuspended in the “breaking buffer” (20mM Tris-Cl, pH=8.0;
150mM NaCl; 5mM MgCl2 and 1mM EDTA in the presence of
1mM PMSF, 0.1mg/ml DNase, 1x Inhibitor cocktail, 250µg/ml
lysozyme). The mixture was then incubated on ice for 30min and
sonicated (8x20sec). The membrane fractions were collected by
a centrifugation at 100000xg fot 35min and the supernatant was
discarded. The crude membranes were completely resuspended
into the “solubilizing buffer” (20mM Tris-Cl, pH=8.0; 100mM
NaCl; 50mM KCl; 5mM MgCl2 in the presence of 1mM PMSF,
5mM imidazole and 750µM β-mercaptoethanol) and the deter-
gent LDAO was added at the final concentration of 10mM. The
mixture was incubated at 4◦C for 3 hours and the unsolubi-
lized fractions were spun down at 100000xg for 1 hour at 4◦C.
The cleared supernatant was loaded onto 1.5ml of cobalt metal-
affinity resin (Sigma). The resin was washed with 20 column
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volumes of “washing buffer” (20mM Tris-Cl, pH=8.0; 100mM
NaCl; 50mM KCl; 5mM MgCl2; 5mM imidazole and 750µM
β-mercaptoethanol in the presence of 10mM LDAO) and then
eluted with 4 column volumes of “elution buffer” (20mM Tris-
Cl, pH=8.0; 100mM NaCl; 50mM KCl; 5mM MgCl2; 300mM
imidazole and 5mM LDAO).
All the purification steps were analyzed by western-blot (Fig.
3.16). As the figure shows, the elution fractions (E1-3) appear
to be degradated with a predominant band at 10kDa (asterisks),
although a significant portion of the protein is in the monomeric
and dimeric form. A bioinformatic prediction (via the XtalPred
server [53]) revealed, in fact, that the N-terminal tail of KvSynth1
(aa 1-100) is a random-coil domain, probably prone to itself
degradation. The next optimization step will include the de-
sign of a new construct without the unfolded N-terminal domain
of the protein, followed by two steps of purification (affinity gel
and size-exclusion chromatography) to get a 90% pure protein
for biophysical and structural studies.
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Figure 3.16: Western-blot analysis of KvSynth1 purification. M:
molecular weight marker (Fermentas); E1-3 elution fractions. The protein
elutes in two fractions for a total volume of 5ml. The predominant forms of
the protein are the monomer and the dimer, although a significant fraction
is a low-molecular weight degradation (asterisks).
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4 DISCUSSION (and future prospects)
Voltage-gated channels control different mechanisms in excitable
cells, so they have been for a long time the object of a intense
research [9]. The first studies started from the Hodgkin-Huxley
model describing the action potential [54], to the identification of
the proteins involved in this process as discrete identities. Then,
with X-ray crystal structures and structure-function studies it
was possible to provide the molecular description of the con-
formational changes in voltage-gated channels, that allow the
coupling between sensing membrane potential and developing
a conductance. Anyway, many aspects of their functioning is
still unknown, because ion channels are sophisticated proteins,
in which different control mechanisms are operating simultane-
ously. In Shaker there are three different type of inactivation
of the conductance: N-, C- and P-type, and each of this can
overlap with the voltage sensor control. Moreover some types of
regulation can involve the recruitment of different subunits, af-
fecting the behaviour of the channel. For these reasons, it could
be difficult to isolate a single mechanism without the interfer-
ence of other factors. An example is that the electrophysiology
characterization of the prototype of voltage-gated K+ channel,
Shaker, had to be done removing the N-terminus of the protein,
that causes inactivation of the current. Another case is the am-
biguity in the assignment of the “mode-shift” to a voltage sensor
properties or to an influence of the pore, as described in 1.1.3,
due to the presence of C-type inactivation. Therefore, in order to
understand the basic principles of voltage-dependence, it could
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be useful to approach the problem recreating the mechanism ab
initio, following what probably happened during the evolution,
when the precursor of voltage-gated channel formed by fusion
of two independent modules. The fusion of genes is one of the
ways in which two proteins are brought together in a cell, to
form a complex system of co-localized domains [1]. The results
obtained by fusing the voltage sensor of Ci-VSP and the K+
channel Kcv, strongly indicates that this is sufficient to trans-
form a voltage-independent K+ channel into a canonical Kv type
outward rectifier. These finding has several corollaries. First, it
is a common opinion that the voltage sensor of Ci-VSP shares
high similarity with the one present in channels, but now we have
demonstrated that it can not only control phosphatase activity
but also gate a pore: the voltage sensor, although present in dif-
ferent proteins, has a unique way to work, so the basic function
of voltage sensing is an intrinsic property of the domain, and
the effect of its movement depends only on the module that it is
fused to.
Second, a covalent link between the two modules, without any
co-evolution of the interacting surfaces, is sufficient to provide
a mechanical interaction, and, not an obvious consequence, the
electrical coupling among them. In fact it has been shown that
in Shaker channel, the most important interactions for the VSD-
pore coupling occur between the S4-S5 linker and the -COOH
terminus of the S6 segment [37]. However, in KvSynth1 the cou-
pling between the two modules is established without any pre-
existent interaction. Third, the interaction between the two el-
ements in KvSynth1 is provided by a linker, that establishes the
rectification of the chimera. The quality of the rectification, i.e.
how the VSD triggers the attached channel pore domain to open
only at depolarizing potentials, mostly depends on its length, in
particular KvSynth constructs showed voltage-dependence with a
linker in a range of 20-6 aminoacids, with optimal condition at
12-6 aminoacids linkers. We don’t have any structural informa-
tion on these linkers, to highlight if specific secondary structures
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are preferred, although in two cases the same length gave the
same rectification degree. The key role of the linker has been
recently confirmed by µs MD simulation on the Kv1.2/Kv2.1
chimera [23], in which, during activation, outward S4 motion
tightens the VSD-pore linker, perturbing linker-S6-helix pack-
ing. Fluctuations allow ions to enter the pore, and this state is
stabilized by the linker-S6 [29].
Of course, without a crystal structure, it’s difficult to know if
interactions between the linker and the S6 are established in
KvSynth1 as in voltage-gated channels, but from this MD results
the authors concluded that the length of the linker in voltage-
gated channels is not of secondary importance: “The S4-S5 linker
is tense in the activated state but relaxed in the resting state,
perhaps explaining conservation of linker length: a shorter linker
would inhibit channel closing, because S4 could not translate
inward far enough, and a longer linker would inhibit opening,
because even full S4 outward translation could not lead to an
effective pull on the pore through the linker.” [29]. This is con-
sistent with what we found in KvSynth: short (4aa) and long
(28aa) linkers cannot control properly the opening and the clo-
sure of the pore.
The last conclusion is that the versatility of the voltage sen-
sor of the Ci-VSP, that can be adapted to different proteins,
a channel or an enzyme, is in agreement with the theory that
evolution has probably exploited the same gating pathway to
regulate proteins involved in different cellular functions [55]. In
allosteric proteins, if we define allostery as a “structural change,
in the tertiary structure, the quaternary structure or both, in-
duced by a small molecule or another protein” [1], the presence of
a linker is required to co-localize two proteins that can establish
an interaction. In our case the linker have a specific functional
role: specific interactions could even improve the quality of the
collaboration between the voltage sensor and the pore, and this
is exactly what, in coevolved modules that form voltage-gated
channels, the evolution did: in fact, “colocalization gives evolu-
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tionary processes the opportunity to convert nonspecific binding
interactions into interactions that have functional consequences”
[1].
Moreover, KvSynth1 can be considered a useful tool to investigate
many aspects of the voltage-dependence mechanism. First of all,
it would be interesting to measure “gating” currents in KvSynth1
with cut-open voltage clamp technique, and to compare them
with the current recorded from Ci-VSP, to see a possible influ-
ence of the presence of the pore. Moreover, gating currents, to-
gether with noise analysis could give information about the num-
ber of electronic charges required to open the pore. The shallow
voltage-dependence of Ci-VSP [5] suggests that few charges are
moved in this voltage sensor, but our results demonstrated that
they are enough to trigger the pore opening. Since in voltage-
gated channels the voltage sensors act independently with a final
cooperative step, it would be interesting to understand how the
voltage sensors of KvSynth1 work together to open the pore.
Finally, KvSynth1 can be a good candidate for crystallization,
since it is nicely expressed and purified from E.coli. The crys-
tal structure could give new insights about the coupling interac-
tions between the two elements, and information about the linker
structure in the different constructs that we tested in oocytes.
Moreover, the right-shifted voltage-dependence of the chimera
(inherited from Ci-VSP) respect to all the other Kv channels
keeps the voltage sensor in the “resting” state in crystallization
conditions (i.e. 0mV). The X-ray structure of this state will al-
low to compare the two extreme conditions that the channel is
subjected to, when the membrane potential changes.
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Part I(b)
La giraffa ha il cuore lontano dai pensieri. Si e´ innamorata ieri, e ancora
non lo sa.
Stefano Benni
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5 STATE OF THE ART
5.1 HCN channels
Within the superfamily of voltage-gated channels, there is a
group of ion channels regulated by cyclic nucleotide ligands,
that includes cyclic nucleotide-gated (CNG) channels and the
hyperpolarization-activated cyclic nucleotide (HCN) channels.
The two families exhibit high sequence similarity, they have sim-
ilar structure, and similar mechanism of activation by cyclic nu-
cleotides [56]. However HCN channels are voltage-dependent,
whereas CNGs are virtually voltage-independent, so the effect
of the cyclic nucleotide modulation on the current is different in
the two groups. They play a fundamental role in a variety of
physiological processes, sharing a regulation mechanism: open-
ing in response to intracellular cyclic nucleotides, they trans-
late this change in a variation of the membrane potential. The
HCN family, like the CNG family, comprises several subunit
types.There are four subunit isoforms, HCN1-HCN4, which can
combine to form heterotetrameric channels in heart and brain
[57–59]. HCN1 is expressed in photoreceprtors, dorsal root gan-
glia, cortex, cerebellum and sinoatrial node. HCN2 is expressed
in sinoatrial node, dorsal root ganglia, and basal ganglia. HCN3
is widely expressed in brain, while HCN4 is expressed in the
sinoatrial node and in subcortical areas [57–59]. HCN chan-
nels are cation channels,more permeable to K+ than Na+, and
they are activated by membrane hyperpolarization. They are
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the molecular basis of the time-dependent inward current known
as If (funny), or Ih, and their function has been extensively de-
scribed in the cardiac sinoatrial node [60, 61]. This area is the
pacemaker of the heart, in which several types of channels coop-
erate to generate spontaneous rhythmic firing of action poten-
tials. After an action potential, the membrane hyperpolarization
activate these channels, that conduct an inward current and de-
polarize the cell, setting the membrane potential to the threshold
of voltage-gated Ca2+ channels activation, leading to a new ac-
tion potential [62]. Some neurotransmitters can increase the con-
centration of cAMP, accelerating the firing, and, as consequence,
the heart beat. This effect is due to the regulation mechanism
of cAMP (3’-5’-cyclic adenosine monophosphate) that bind to
HCN channels, shifting the voltage dependence of the activation
to more depolarizing potentials, the rate of channel opening and
the maximal conductance [63].
In a similar way, HCN channels mediate pacemaker activity in
the nervous system. Besides acting as pacemaker, HCN chan-
nels can also stabilize the membrane resting potential. In fact
they are activated at rest, leading to an inward sodium cur-
rent that depolarize the cell. This depolarization deactivates
HCN channels, preventing too rapid firing [56]. Since they have
an important role in the heart and brain activity, mutations in
these channels are related to several diseases like bradycardia
and epilepsy, as it was recently demonstrated [64, 65].
5.1.1 Topology of HCN channels
HCN channels present structural features common to the chan-
nels belonging to the superfamily of voltage-gated channels. They
have six transmembrane segments, four of them (S1-S4) form the
voltage sensor domain, while S5-S6 comprise the pore region,
thought to be similar to that of KcsA, whose crystal structure
has been solved. HCN channels have both intracellular N- and C-
termini [56]. The N-terminus is different in every isoform, while
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the C-terminus, connected to the end of S6 segment, is for the
most part formed by cyclic nucleotide binding domain (CNBD)
and the C-terminal called post-CNBD (Fig.5.1) [56].
Figure 5.1: HCN channels membrane topology Cartoon represen-
tation of two monomeric subunits of an HCN channel. It’ s possible to
identify all the elements: the voltage sensor domain (black), the pore (red),
the C-linker (green) connecting S6 with the CNBD (cyan) [56]
The selectivity filter has the conserved sequence found in e
K+ channels (GYG motif), but HCN channels are permeable to
K+ and Na+ with a ratio of 4:1, and blocked by Cs+ [66]. The
voltage sensor contains the positive charged residues responsible
of the S4 motion upon changes in membrane potential. HCN
are moderately voltage-dependent, with an average of six equiv-
alent charges moving to activate the channel, compared to 13eo
of Shaker, and they have slow activation kinetics [56]. The volt-
age dependence is different in tetramers formed by identical sub-
units. Both the S4 movement and the activation gate appear to
be conserved between HCN and Kv channels. Because they open
in response to voltage steps with opposite polarity, it is presum-
able that the coupling between the two elements is different [67].
The three isoforms of HCN channels, when expressed as homote-
tramers, show different kinetics and voltage dependence. HCN1
has the faster kinetic and less negative threshold of activation,
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the current reaches the saturation level at less negative potential
respect HCN2 and HCN4 [68].
Figure 5.2: Representative current traces of heterologously ex-
pressed HCN1, HCN2, HCN4 homotetramers. Current traces are
recorded at hyperpolarized voltage steps. The traces clearly show that
HCN1 exhibits the fastest kinetic and the more positive voltage depen-
dence. In fact, the current developed by HCN1 reaches saturation at less
negative voltages respect HCN2 and HCN4. (From www.chantest.com)
5.2 cAMP modulation
5.2.1 Effect of cAMP on channel gating
HCN channels are activated by the membrane hyperpolarization,
but channel opening can be modulated by cyclic nucleotides, in
particular cAMP and cGMP [56, 63]. These molecules can bind
in a pocket within the CNBD, affecting the open probability of
the channel: binding of cAMP at nanomolar concentration shifts
the voltage-dependence to more depolarized potentials, speeds
the kinetics and increases the maximal conductance of the chan-
nel [56]. Nevertheless the intensity of the effect is different in
HCN1 respect HCN2 and HCN4: in the latter the shift due to
cAMP binding is around 17mV, while in HCN1 is only 3 mV
[68]. Similar effects are obtained by cGMP, but 10-fold higher
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concentration of ligand is required, due to lower affinity of this
agonist [69].
Figure 5.3: HCN1 and HCN2 voltage-dependence and cAMP
dose-response curve in patch-clamp measurements. The heterolo-
gous expression of HCN1 and HCN2 show that the activation curve of HCN1
is right-shifted respect to HCN2. The presence of cAMP shifts HCN1 V1/2
of about 3mV, and HCN2 V1/2 of about 17mV. The dose-response curves
reveal a Kd for cAMP of 60nM for HCN1, and 100nM for HCN2 (Modified
from [70]).
5.2.2 The structure of the CNBD in HCN
channels
The CNBD is the cytosolic regulatory domain in charge of the
response of the channel to the binding of cyclic nucleotides. De-
spite a difference in the channel gating effect recorded in elec-
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trophysiology of HCN1 respect to HCN2/4, the three crystal
structures appear very similar (Fig.5.4), in agreement with the
high sequence identity (∼ 90%) [8, 71, 72]. The cytosolic re-
gion crystallized is composed of two subdomains: the CNBD
and the C-linker. The CNBD consists in the binding pocket
for nucleotides, and it is formed by four α-helices with a β-roll
in between. The β-roll architecture is composed of eight anti-
parallel β-strands. The binding site for nucleotides looks like a
pocket formed by helices C and P and β-sheet 7; in particular
the comparison between the unbound and bound structures of
an homolog CNBD from M.loti show a movement of 8A˚ of the
C-helix acting as a gate that seems to trap the molecule of cAMP
in the pocket [73].
Figure 5.4: Structures of C-terminal domain of three HCN iso-
forms. Ribbon representation of a single subunit of C-linker/CNBD with
the cAMP bound in the pocket, of mouse HCN2 [71], human HCN4 [72]
and mouse HCN1 [8]. Each helix is marked with a letter.
The CNBD assembles as a tetramer in presence of cAMP.
The tetramerization of the CNBD subunits is usually correlated
to the removal of tonic inhibition from the pore of HCN chan-
nels, facilitating pore opening [8, 71, 72]. The inhibitory effect
is supported by the fact that the deletion of CNBD in HCN
channels accelerates the activation kinetics and shifts the volt-
age dependence to more positive voltages [4]. Although the three
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isoforms don’t diverge so much in the structure, HCN1 has a
different response to cAMP (lower shift of V1/2). In a previ-
ous study published by our laboratory we demonstrated that
HCN1 has a higher propensity to tetramerize at basal levels
of cAMP [8]. The crystal structure has been obtained also in
presence of cGMP: this nucleotide allocates in the same binding
pocket, but in syn configuration, instead of the anti configuration
found in the cAMP-bound CNBD [71]. It has been shown that
the affinity of cGMP for HCN2 is lower respect to cAMP (K1/2
cAMP=0.09µM; K1/2 cGMP=1.4µM in inside-out patches) [74].
This reduced efficacy of cGMP has been investigated in HCN2.
In particular, the insertion of a point mutation in the C-helix,
I636D, converts the cAMP effect into the one of cGMP, and
viceversa.The authors suggest that cGMP is only a partial ag-
onist in wild-type channels because it is unable to sufficiently
stabilize movement of the C helix, or that because the C helix is
in a different conformation with cGMP bound than with cAMP
bound, and the mutation causes the C helix to adopt a cAMP-
like configuration in presence of cGMP [75].
Most of the intersubunits contacts in the three crystals are in
the C-linker. The C-linker connects the last transmembrane seg-
ment to the cyclic nucleotide binding pocket, is made of six α-
helices interspersed by short loops. The C-linker has a charac-
teristic fold, in which the first two helices (A’,B’) form an anti-
parallel helix-turn-helix motif interacting with the helices C’ and
D’ of the neighbouring subunit (Fig.5.5. These interaction has
been likened to an “elbow on shoulder”, and it involves hydro-
gen bonds, hydrophobic interactions and salt bridges [71]. Elec-
trophysiological data derived from HCN1/2 chimeras assigned
differences in cAMP modulation to differences in the C-linker
region [70]. All these results suggested that cAMP binding in-
duces a significant rearrangements at the level of the “elbow on
shoulder”, and, consequently, to the whole C-terminal region.
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A B
Figure 5.5: Elbow-on-shoulder between two C-terminal domain
neighbouring subunits. (A) Cylinder representation of a tetramer from
the side view with the cAMP bound. Helices B’ and C’ of the red subunit
interact with helices C’ and D’ of the green subunit. (B) Residues involved
in the interaction in HCN2 [71].
5.2.3 Cooperativity of CNBDs
Quite a few mechanisms have been suggested to explain cyclic
nucleotide activation of HCN channels, but they are still evolv-
ing in relation to the more recent data [76, 77]. The MWC
model was proposed to explain this mechanism (Fig.5.6 B): it’s
a classic allosteric model (the same used to explain haemoglobin
behaviour), with transitions from the closed to open state stabi-
lized by a constant amount of bound ligand. It is based on the
assumption that there are four identical binding sites, and the
channel opening occurs with a single concerted final transition of
the whole protein [56]. To address this limitation two are models
were proposed.
The first is the dimers of dimers: the CNBDs are organized
as dimers; the dimer undergoes to a concerted transition from
closed to open, but both dimers must be open to enhance open-
ing of the pore [78]. This model implies that the CNBDs are
organized in a two-fold symmetry in the apo-state (unbound),
but they recover the four-fold symmetry when they are fully lig-
ated, as the crystal structure shows (Fig5.6 A).
Anyway, the model that fit in the best way with the crystal struc-
ture, could be the modular gating model (Fig.5.6 C) [56]. The
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activation of HCN channels can be described as the interaction
between four modules:the pore, the voltage sensor, the C-linker
and CNBD. Each module is in equilibrium between two possible
conformations, and they are coupled so that the conformation of
one module can be influenced by another module. This model is
used to explain why in the crystal the C-linker is in the resting
conformation, which is inhibitory for the pore, while the CNBD
is bound by the ligand. The absence of the pore in the crys-
tallized construct can promote the resting state of the C-linker,
although the CNBD is “loaded”.
Figure 5.6: Proposed models for cAMP modulation in HCN chan-
nels. Schematic representation of dimers of dimers (A), MWC (B) and
modular gating (C) models. (Modified from [56])
The last results, obtained with Isotermal Titration Calorime-
try (ITC) on isolated C linker-CNBD [79] and patch-clamp fluo-
rometry [76, 77], provided new insights in the description of the
cooperativity between the four CNBDs.
By ITC experiments it was possible to measure two affinity states
in HCN2, an high affinity state (0.1µM), due to the binding of the
first cAMP molecule, and a lower affinity state (∼1µM) where all
the binding sites are completely occupied. The same experiments
on HCN1 highlighted that only the lower affinity state is measur-
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able, so the authors suggested that the changes induced by the
high affinity binding of cAMP have already occurred. This could
explain the different effect of cAMP on HCN1 in terms of chan-
nel opening. The authors suggested that a negative cooperativity
can be derived from their data: the binding of the first molecule
decreases the affinity for the other binding sites. The difference
in binding affinity was also observed on the whole channel by
patch-clamp fluorometry, but with different conclusions. These
experiments are done with a fluorescent analog of cAMP, allow-
ing to track binding event and current flow at the same time.
The more relevant results from these experiments were that in
HCN2, two molecules of cAMP are enough to modulate channel
opening, and that the cooperativity of HCN channels is a high
complex process. The subunits substantially differ for binding
affinity: the binding affinity for the second ligand is larger than
the first ligand to be bound, and similarly the affinity for ligand
4 is larger that that for ligand 3. However, although in these
cases we can observe a positive cooperativity, the affinity for lig-
and 3 is smaller than that for ligand 2. This suggests a negative
cooperative effect. The channel is stabilized only in the states
with zero, two or four ligands: it is possible to suppose that the
activation process occurs thanks to a dimeric organization [76].
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6 AIMS OF THE PROJECT
6.1 A putative second binding pocket
for nucleotides
In our laboratory we crystallized the C-terminal region of HCN1,
HCN2 and HCN4 in presence of cGMP. Carefully analyzing these
structures, we found an unexplained electron density in all the
three proteins, particularly marked in HCN4. This additional
density is c-GMP specific, and it is located in the C-linker region,
close to the tetramerization interface of the subunits. Several
rounds of refinement showed that the density corresponds to a
cGMP molecule (Fig 6.1). The presence of a cyclic nucleotide in
a region, so important in the transmission of the signal due to
cAMP binding to the pore, suggested us to explore the possibility
that occupancy of this site by a cGMP molecule could affect the
properties of the channel.
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Figure 6.1: Additional electron density in HCN4. Crystal struc-
ture on the C-linker/CNBD of HCN4. The cAMP molecule is bind in the
canonical pocket in the CNBD. A cGMP molecule is bound in the C-linker
region, in the loop between helices B’ and C’. (Fig. by M. Lolicato)
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7 RESULTS
Although it is known that channels that regulate the pacemaker
activity are modulated not only by cAMP, but also by cGMP,
so far there is no evidence if cGMP has an effect on HCN4. The
only measurements available showed the effect of cGMP on the
native current If [63]. For this reason we tested the effect of
cGMP on HCN4 homotetramers, to compare its effect with that
reported for HCN2. Moreover, the presence of a cGMP molecule
in the putative binding site in the C-linker, suggested us that
cGMP could bind there when it is added at high concentration,
giving a feedback regulation. The experiments were performed
expressing HCN4 in mammalian HEK 293 cells. Inside-out patch
clamp recordings from these channels showed a behaviour very
similar to that reported for the native current If . cGMP was
applied on excised-patches after recording the current in control
solution; the effect of cGMP is concentration-dependent, the KD
derived from fitting experimental data with the Hill equation is
13.2µM, while n is 0.72. The maximal shift is 12mV, smaller
than that cAMP induces on the current (Fig.7.1). All this data
are consistent with the effect of cGMP on HCN2 (ref), where
cGMP gives similar modulation of cAMP. To exclude that cGMP
exerts side effects on the current by binding in the second pocket,
high concentrations of nucleotide were tested. Five and 10mM
cGMP were added to bath solution in excised patches, resulting
in the same 12mV shift of the current. cGMP have no effect even
when the canonical binding pocket was fully ligated by cAMP
(5mM).
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Figure 7.1: Dose-response curve of cGMP on HCN4 current. Ex-
periments were performed in excised patches of HEK cells transfected with
hHCN4. Experimental data (n≥ 3) were averaged and fitted with Hill equa-
tion. Kd=13.2µM; n=0.72. Exp. performed by S. Zucca.
At this point we excluded occupancy by cGMP of the second
binding site could exhert any measurable effect on the current.
A more detailed analysis of the structure revealed that the por-
tion of the protein in which the second cGMP was found, is rich
of charged residues that create a deeper tunnel (compared to
the cGMP electron density) able to allocate a bigger molecule.
Starting from this consideration, we tried to fit a molecule of c-di-
GMP in the pocket, obtaining a good overlap with the electron
density and interaction with the charged residues of the “tun-
nel”. Cyclic -di-GMP is a signalling molecule found in bacteria
that is composed by two molecules of cGMP bound at the cyclic
phosphate level (Fig.7.2). So we tested the effect of c-di-GMP
in vivo in whole-cell configuration, adding the agonist in pipette
solution [64].
The presence of 100µM c-di-GMP in the pipette solution did
not affect the currents of HCN4, that appeared indistinguishable
from the control. Anyway, a dramatic effect could be observed if
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Figure 7.2: c-di-GMP molecule.
the same experiment was done in presence of cAMP. Compared
to the activation curve obtained with cAMP alone, the presence
of the c-di-GMP completely abolishes the effect of cAMP, shift-
ing back the activation curve to control position (Fig.7.3).
This reverting effect of c-di-GMP on cAMP modulation is
measurable also in excised patches. In single-step experiments,
the current is recorded in control solution. cAMP addition at sat-
urating concentration increased the current, and the c-di-GMP
shifted back the current to the control recordings. This demon-
strated that c-di-GMP directly affects HCN4 current (Fig.7.4).
Whole-cell experiments revealed a Kd of 1.58± 0.24 µM and
a n value of 1.2 (Fig.7.5). We obviously tried to co-crystallize
HCN4 CNBD in presence of this molecule, to demonstrate that
c-di-GMP binds in the second pocket, and to analyze the inter-
action between the dinucleotide and that portion of the protein.
Unfortunately any attempt to get crystals with good diffraction
patterns failed, probably because the conformational changes oc-
curring from c-di-GMP binding, destabilizes protein organiza-
tion.
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Figure 7.3: Effect of c-di-GMP on HCN4 current. The effect of
c-di-GMP was tested in HEK cells transfected with hHCN4 in whole-cell
configuration. (A) Representative current traces recorded in control solu-
tion, plus cAMP, and plus cAMP and c-di-GMP. (B) Top panel: Activation
curves from experimental data obtained with and without c-di-GMP 100µM
in pipette solution. V1/2(+c−di−GMP )=−99.0±0.6, V1/2(control)=−98.4±0.6
mV. Bottom panel: Activation curves from experimental data recorded in
pipette control solution, with cAMP 15µM and with both cAMP 15µM
and c-di-GMP 100µM. V1/2(control)=−94.9±0.3, V1/2(+cAMP )=−78.4±0.2,
V1/2(+c−di−GMP+cAMP )=−94.8± 0.6 mV. Data are obtained from average
of n≥ 3 experiments.
At the same time we could solve the structure at 3.7 A of
the protein co-crystallized with another di-nucleotide, the c-di-
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Figure 7.4: The c-di-GMP affects directly cAMP modulation.
Single-step current trace recorded at -140mV of hHCN4 in inside-out con-
figuration. Current recorded in control condition (black line) increases upon
the addition of 1mM cAMP (red line). The c-di-GMP completely reverts
the effect of cAMP, the current goes back to the level measured in control
solution (green line). Fig. by S. Zucca.
Figure 7.5: Dose-response curve of c-di-GMP on HCN4 current.
Experiments were performed in whole-cell configuration in HEK cells trans-
fected with hHCN4. Experimental data (n≥ 3) were averaged and fitted
with Hill equation. Kd=1.58± 0.24µM; n=1.2. Fig. by S. Zucca.
AMP, bound in the second pocket in the C-linker region. The
crystal structure is at low resolution, so it is not possible to see
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the side chains interacting with c-di-AMP, that binds only in
two monomers on a total of sixteen found in the cell unit of the
crystal. For comparison, cGMP was found in each monomer of
the cell unit. Electrophysiology experiments showed that adding
100µM c-di-AMP in the pipette solution counteracts the effect
of cAMP, displaying the same effect of c-di-GMP (Fig.7.6). This
underlies that also this dinucleotide can dramatically perturb
the CNBD structure, but it probably establishes different in-
teractions, allowing the formation of a stable crystal. Another
explanation can be that the presence of fewer molecules of c-di-
AMP allows the tetramers to keep an ordered structure.
In silico docking the c-di-GMP in the binding pocket identi-
fied in the C-linker of HCN4, in three different poses, revealed
that the glutamate in the position 566 could be an interaction
point. It has been shown before that this aminoacid is conserved
in HCN2, and is related to epilepsy when is mutated in aspartic
acid [65]. This mutation causes a pronounced left-shift in the
activation curve of HCN2, but the channel is still able to bind
and respond to cAMP, with the same maximal shift of the V1/2
recorded in the wild-type. The mutation E566K in HCN4 showed
a similar behaviour to what has been reported in HCN2 [65]. In
control pipette solution the V1/2 is −129.3±0.2 mV; experiments
with cAMP 15µM causes a shift to a V1/2 of −114.1 ± 0.1 mV.
Furthermore, as expected by our docking results, the c-di-GMP
doesn’t influence the effect of cAMP, as shown in Fig. 7.6 the
two curves are superimposed. The residue E566 is clearly in-
volved in the interaction with the c-di-GMP, and this confirms
that the dinucleotide binds in the non-canonical pocket within
the C-linker.
As a control experiment, the c-di-GMP was docked in the
canonical binding site of HCN4 structure after removal of cAMP.
The docking software failed to get output a score because the
molecule is too large for that pocket.
At this point, we collected several evidences that in the C-
linker there is a binding pocket that can regulate the response
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Figure 7.6: The C-linker region hosts a second binding
pocket. (A) Activation curves of HCN4 recorded in presence of cAMP
15µM and cAMP 15µM+c-di-AMP 100µM (V1/2(+cAMP )=−82.7 ± 0.2,
V1/2(+c−di−AMP+cAMP )=−96.3± 0.3 mV). (B) Crystal structure of HCN4
Clinker-CNBD bound to a molecule of c-di-AMP. The molecule of c-di-
AMP localized near the loop between B’ and C’ helices. (C) Activa-
tion curves of HCN4 E566K recorded in control solution, in presence of
cAMP 15µM and cAMP 15µM+c-di-GMP 100µM (V1/2=−129.3 ± 0.2,
V1/2(+cAMP )=−114.1 ± 0.1, V1/2(+c−di−GMP+cAMP )=−114.6 ± 0.1 mV).
(D) Crystal structure of HCN4 Clinker-CNBD bound to the c-di-GMP
docked in three different poses. Aminoacid E566 interacts in all the three
possible docked structures. Data are obtained from average of n≥ 3 exper-
iments.
of the cAMP and that this pocket can bind not only cGMP
but also larger molecules as c-di-nucleotides. More than 300.000
molecules were screened and the top 11 ranked according to the
calculated affinity were tested on HCN4. These molecules were
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divided in two groups and tested separately in whole-cell exper-
iments, adding each mix to the pipette solution, in the presence
of cAMP. Each mix contained each compound at a final concen-
tration of 100µM; the selected molecules are highly insoluble, so
they were dissolved in DMSO. We tested only the molecules able
to dissolve in pipette solution at a final concentration 100µM.
The pipette solution had a maximum concentration of DMSO
of 0.3%. Control experiments were done maintaining the same
DMSO concentration in the pipette solution, to exclude any pos-
sible effect of the solvent. Table7.1 shows the V1/2 recorded for
the two mix. Cells measured in presence of Mix n.1 has an half-
activation potential similar to that recorded in presence of cAMP
alone, so none of these molecules is able to counteract the effect
of the cAMP. Anyway, the Mix n.2 shifted the activation curve
at the same position of the control experiments, so at least one
of the molecule in the mixture is able to act as an antagonist of
the cAMP.
V1/2 ∆V1/2 (V1/2cAMP − V1/2x)
Control -93.9±0.07 14.1± 0.4
cAMP −79.8± 0.3 -
MIX 1 −81.9± 0.1 2.0± 0.4
MIX 2 −96.3± 0.5 16.4± 0.8
MIX 2 components
n.5 −82.7± 0.3 2.8± 0.6
n.8 −79.9± 0.4 0.05± 0.4
n.11 −96.4± 0.8 16.6± 1.1
Table 7.1: Effect of Mix n.1 and Mix n.2 on HCN4 current. The
11-top ranked compounds obtained docking the second binding pocket were
grouped in two mix. Each mix was added in the pipette solution with cAMP
15µM. The table shows the V1/2 for each condition and the ∆V1/2 respect
the V1/2 calculated for cAMP recordings. The compounds of Mix n.2 were
individually tested, and the n.11 has been identified as the compound able
to revert the cAMP effect.
The molecules in mix n.2 were individually tested, and only
one was responsible of the phenotype observed in the mixture.
The IUPAC nomenclature of this molecule is N’-biphenyl-2-yl-N-
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[1-(3-cyanobenzyl)piperidin-4-yl]-N-(pyridin-3-ylmethyl)urea, here-
after called compound n.11. The effect of the compound n.11 is
exactly the same observe with the c-di-GMP, and with the c-di-
AMP, but the dose-response curve revealed that it has higher
affinity (Kd=0.42± 0.11µM) (Fig.7.7).
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Figure 7.7: The compound n.11 affects cAMP modula-
tion of HCN4. (A) Compound n.11: N’-biphenyl-2-yl-N-[1-(3-
cyanobenzyl)piperidin-4-yl]-N-(pyridin-3-ylmethyl)urea. (B) Activation
curves of HCN4 in pipette control solution, in presence of cAMP, and
cAMP+compound n.11. (V1/2=−93.9 ± 0.1, V1/2(+cAMP )=−79.85 ± 0.3,
V1/2(+n.11+cAMP )=−96.4±0.8 mV)(C) Activation curves of HCN4 in pres-
ence of cAMP 15µM and the compound n.11 at the concentration of 0.1 ( ),
1 ( ), 10 ( ), 100µM ( ). (D) Dose-response curve of compound n.11 mea-
sured as ∆V respect to the V1/2 in presence of cAMP. KD is 0.42±0.11µM.
Data are obtained from average of n≥ 3 experiments.
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7.1 Isoform specificity on the effect of
c-di-GMP and compound n.11
The C-linker is very conserved in the three isoforms of HCN
channels. In order to test isoform-specificity, we repeated the
experiments with the c-di-GMP and with the compound n.11
on HCN2. In particular, the residues identified as relevant in
the binding of cGMP and c-di-AMP, or c-di-GMP (docking) are
identical in HCN2 and HCN4. At the same time, as mentioned
in the introduction, the presence of the electron density seemed
from the beginning to be isoform-specific, more marked in HCN4
than in HCN2. Cells expressing HCN2 had a V1/2 of −94.0 ±
0.1mV in control solution. The addition of cAMP 15µM shifted
the V1/2 to a value of −74.2 ± 0.5 mV. Cyclic-di-GMP 100µM
didn’t show any effect on HCN2 current, and we had to increase
the concentration of antagonist up to 200µM to observe a shift of
∼6mV in the activation curve (Fig.7.8). The compound n.11 was
totally ineffective even at the concentration of 200µM (Fig.7.9).
The binding pocket that we identified could be considered
as a potential target for drugs, because different molecules, se-
lected in independent ways, affect in the same manner the chan-
nel opening in the micromolar and submicromolar range.
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Figure 7.8: Effect of c-di-GMP on HCN2 current.
Activation curves of HCN2 recorded in control pipette so-
lution ( ), in presence of cAMP 15µM ( ) and cAMP
15µM+c-di-GMP 100 ( ) and 200µM ( ) (V1/2=−95.9 ± 0.7,
V1/2(+cAMP )=−74.7 ± 0.5, V1/2(+c−di−GMP100+cAMP )=−74.2 ± 0.7,
V1/2(+c−di−GMP200+cAMP )=−80.6± 0.6 mV).
Figure 7.9: Effect of compound n.11 on HCN2 current. Activation
curves of HCN2 recorded in control pipette solution ( ) , in presence of
cAMP 15µM ( ) and cAMP 15µM+n.11 100µM ( )(V1/2=−95.7 ± 0.8,
V1/2(+cAMP )=−74.6± 0.6, V1/2(+n.11+cAMP )=−72.6± 0.4 mV).
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7.2 Effect of compound n.11 on the
native current If
Since HCN4 is the major molecular determinant that underlies
the current in the sino-atrial node of the heart, we tested the
compound n.11 on the native current If , in collaboration with
the laboratory of Prof. Dario DiFrancesco (University of Milan,
Italy). The experiments were performed in isolated myocytes of
the mouse sino-atrial node, in whole-cell configuration, in which
the compound was added to the pipette solution. The activa-
tion curve recorded in presence of the compound n.11 alone was
already left-shifted respect to the control curve: the molecule
counteracted the effect of the endogenous cAMP bound to the
channel. Anyway, the two activation curves recorded in the pres-
ence of the compound n.11, with or without cAMP, are signifi-
cantly left-shifted respect to the curve recorded in the presence of
cAMP alone. As we found in HEK cells, the compound n.11 was
able to revert the shift induced by cAMP on the native current
(Fig.7.2).
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Figure 7.10: Effect of compound n.11 on If in mouse sino-atrial
node myocytes. Traces current recorded at -35mV, -75mV, tail currents
at -115mV. cAMP and compound n.11 are added respectively at the con-
centration of 10µM and 100µM. (V1/2=-76.1mV; V1/2(+cAMP )=-69.3mV
∗; V1/2(+n.11)=-80.5mV; V1/2(+n.11+cAMP )=-78.0mV ∗. ∗, P≤ 0.5 versus
control value.)
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8 DISCUSSION (and future prospects)
In 1991 it has been demonstrated that, in cardiac pacemaker
cells, cAMP activates If by a mechanism independent of phos-
phorylation, involving a direct interaction with the channels at
their cytoplasmic side. This was the first evidence of an ion chan-
nel whose gating is dually regulated by voltage and direct cAMP
binding [63]. In the last years many attempts were done in or-
der to understand which mechanism can translate an increase in
cAMP concentration into an increase of channel opening. The
keystone to interpret the general mechanism is that, upon cAMP
binding, the four cytosolic subunits in every channel undergo to
a tetramerization, a conformational rearrangement between the
subunits that is transmitted to the pore region [8, 78].
In our lab, we now have discovered a new regulation point in
HCN4, sited in the C-linker region that provides most of the
teramerization contact points in the protein. The finding of
a cGMP molecule in this secondary pocket does not seem to
correlate with a new function of this nucleotide in the C-linker
region. The effect of cGMP on HCN4 current, revealed a simi-
lar behaviour previously described in HCN2 [75] and in the na-
tive current If [63]. The cGMP acts as an alternative agonist,
with lower affinity respect to cAMP, interacting with the binding
pocket in the CNBD. Anyway the C-linker binding pocket can
host larger molecules, as the dinucleotides (c-di-GMP and c-di-
AMP) or the screened compound n.11, and, unlike the cGMP,
they can surprisingly counteract the modulation due to cAMP
binding. In fact, in the presence of one of these molecules bound
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in the second pocket, the effect of cAMP on gating can be par-
tially or completely eliminated, in concentration-dependent man-
ner. This binding pocket could be an interesting target for drug
design, because it will be possible to develop molecules that af-
fect the autonomic control on the heart rate, not only in diseases
that involve defects of HCN function but also to relieve side ef-
fects due to other heart therapies. The known HCN blockers, as
ivabradine [80, 81], act as a pore blocker, interrupting the ion
flux through the channel. On the contrary, the exploitation of
this pocket could allow a fine tuning of the channel activity, in
particular when a downregulation of the cAMP effect is required,
without perturbing the cAMP concentration in the cell, that is
involved in many other regulation pathways [82]. The preference
of the molecules that we tested for HCN4, shows a high isoform-
specificity, avoiding a general effect on all HCN channels, that
are widely expressed in heart, brain and also in the retinal cells
[83–85]. The finding of this novel binding pocket raises a great
interest from the biophysical point of view. This binding site
is situated in tetramerization region of the CNBD, a key point
for the trasduction of the cAMP binding effect, a bridge be-
tween the binding event and its efficacy. The presence of this
binding pocket testify that it is possible to severely affect cAMP
modulation acting far from where the binding occurs. How this
inhibition, due to c-di-GMP or related molecules, occurs, has to
be studied in deep. From our preliminar data is difficult to elab-
orate a model of the mechanism of c-di-GMP action.
The first hypothesis could be that the binding of c-di-GMP in-
duces a conformational change that is transmitted to the binding
pocket of the cAMP, and then it changes the affinity of cAMP
for the CNBD. The C-linker region could be an allosteric binding
site, antagonizing the effect of cAMP. This idea can explain why
the co-crystallization of the CNBD with c-di-GMP failed: the
new tertiary and quaternary structure can be less ordered, so
difficult to pack properly (we obtained only diffracting crystals
at 6A˚ resolution). Similar problems have occurred in the crystal-
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lization attempts of the “apo-state” of the CNBD of HCN chan-
nels, i.e. the CNBD without any ligand bound into the pocket [8].
This, again, suggests that lack of tetramerization, together with
the high flexibility of the C-helix in absence of ligand [73, 86],
can interfere with the formation of an ordered crystal. In par-
ticular, the presence of the c-di-GMP could interfere within the
set of interactions established in the “elbow-on-shoulder” [71],
in which, via the C-linker, a subunit can contact the neighbour-
ing one. The crystal structure of HCN4 CNBD in the presence
of c-di-AMP does not show striking changes in the quaternary
assembly, but the c-di-AMP is bound in only two molecules on
a total of sixteen, so the averaged structure of the whole crystal
shows a tetrameric assembly. Moreover, the low resolution of the
crystal, does not allow to estimate if all the interactions present
in the cAMP-bound structure are maintained when also c-di-
AMP is bound. The second hypothesis involves the possibility
that this alternative binding site is due to the quaternary struc-
ture of the C-linker only in the cAMP-bound conformation of
the C-linker/CNBD. In this case, the c-di-GMP could bind with-
out perturbing the cAMP-CNBD interactions. This hypothesis
could explain why the effect of the c-di-GMP is still maintained
even upon addition of high concentration of cAMP (1mM), al-
though the effect of c-di-GMP is reversible (data not shown) .
In order to explain which mechanism underlies the coupling ago-
nist/antagonist, further experiments are required. In particular,
monitoring the binding and unbinding of cAMP would help to
understand which structure rearrangements occur in the pres-
ence of a molecule interacting in the C-linker region. A couple
of options are possible: (1) it’s known that an analog of cAMP,
the 8-Azido-cAMP, binds covalently to the CNBD upon UV ir-
radiation [87, 88]. Once the cAMP is bound to the CNBD, it
will be possible to record or not the effect of c-di-GMP. This will
allow to discriminate if the presence of the cAMP in the binding
pocket is mandatory or not for c-di-GMP effect. (2) Another
analog of cAMP, the fcAMP (8-DY547-AET-cAMP, [77]), binds
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with similar affinity and kinetic to the CNBD, and due to its flu-
orescence, it’s possible to follow the binding event together with
the measurements of the current. Again, this approach could be
useful to understand the events during cAMP/c-di-GMP inter-
action with the CNBD.
However, the interesting insight of our results, is that the C-
linker cannot be merely considered as the covalent bridge be-
tween two domains, the pore and the CNBD, but it is a hub of
interactions and, in particular, all these interactions are responsi-
ble of the relieve of the inhibition exerted from the CNBD upon
cAMP binding. This idea was already demonstrated through
the functional characterization of chimeras between HCN1 and
HCN2, were the C-linker and different parts of the CNBD of the
two isoforms were swapped [70]. What it is known is that the
deletion of the C-linker/CNBD removes the inhibition of this
domain from the channel, shifting the activation curve to less
negative voltages. This means that the voltage sensor requires
less energy to activate the channel. The same effect is obtained
in other two cases: when only the CNBD, but not the C-linker,
is deleted, and when, in the wild-type channel, the CNBD is
fully ligated to cAMP. From these results, the C-linker alone,
does not seem to exert any effect on the transmembrane core
of the protein. This can be due to an unfolding of the C-linker
in the absence of the CNBD, in which intra- and inter-subunit
interactions are lost. The mutant E566K, that we characterized
in HCN4, whose phenotype was already showed in HCN2 [65],
demonstrates that is possible to uncouple the two mechanisms:
the basal position of the activation curve, and the cAMP mod-
ulation. In particular, the left-shifted position of the activation
curve seems to be assigned to the C-linker (more than the C-
linker/CNBD), because the mutation is located in this domain.
In this mutant the energy required to open the channel is so
high respect to the wild-type, than even when the CNBD is fully
ligated, the V1/2 is correctly shifted to a more positive value,
but it cannot reach the same value than that of HCN4 wild type
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(+cAMP: V1/2wt=-82mV; V1/2E566K=-114mV). The mutated
C-linker can exert an inhibiting effect so strong that even the
modulation of cAMP is not enough to remove it; this proba-
bly suggest a change in interactions between the C-linker and
some region of the voltage sensor domain, as the S4-S5 linker.
It was postulated that an electrostatic interaction between the
C-terminal domain and the S4-S5 linker keeps the channel in a
closed conformation. An hyperpolarized stimulus disrupts the
interaction and the open state could be reached [89, 90]. This
interpretation is supported by the phenotype of another HCN4
mutant that we tested: mutations in the position 564 (F564T,
F564A) shift the activation curve to a positive value (-80mV),
and no effect is observed upon cAMP addition. Moreover the
mutation E566K affects the c-di-GMP effect, a confirmation that
this molecule binds in the C-linker region and interacts with this
residue and that involves only cAMP modulation, because all
the other features of the mutant remains unchanged.
The C-linker is a crossroads where distinct signals meet and are
integrated: the voltage sensor can contribute through its move-
ment, the CNBD can modulate the voltage dependence within
a range (0-17mV), and the C-linker is responsible of the synthe-
sis of these signals that must be transmitted to the pore. Since
the modularity of the channels implies that individual modules
maintain their independence [55, 91], a good intermediary is re-
quired to interpret this signals, and the C-linker seems to be the
best candidate in HCN channels.
Our work demonstrate that the C-linker region contains an al-
losteric binding site for cAMP modulation, and the isoform speci-
ficity confirms, in line with our previous studies of different
tetramerization properties of HCN CNBDs [8], that real differ-
ences exist within HCN1, HCN2 and HCN4.
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Abstract:  
The modular architecture of voltage-gated potassium (Kv) channels suggests that they 
resulted from the fusion of a voltage-sensing domain (VSD) to a pore module (PM). Here 
we show that the VSD of Ciona intestinalis phosphatase (Ci-VSP) fused to the viral 
channel Kcv creates KvSynth1, a functional voltage-gated, outward rectifying potassium 
channel. KvSynth1 displays the summed features of its individual components: pore 
properties of Kcv (selectivity and filter gating) and voltage-dependence of Ci-VSP (V1/2 = 
+ 56 mV, z ~1) including the depolarization-induced mode shift. The degree of outward 
rectification of the channel is critically dependent on the length of the linker more than on 
its amino acid composition. This highlights a mechanic role of the linker in transmitting 
the movement of the sensor to the pore and shows that electromechanical coupling can 
occur without co-evolution of the two domains. 
 
Key words: voltage-sensing domain, Ci-VSP, Kcv, Kv channel, synthetic biology 
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Introduction 
Potassium (K+) channels are modular proteins, composed of a central pore module (PM) 
surrounded by sensor domains that perceive external stimuli and convert them into 
changes of pore activity (gating). This feature and simple assessment of their performance 
by electrophysiological measurements make ion channels amenable for testing the 
hypothesis that the pore of Kv channels acquired the voltage- sensing domain (VSD) 
throughout evolution. The modular building concept has several implications. First, it 
suggests that single domains, once detached from the original channel, can function 
independently: for instance the PM of the bacterial KvLm channel forms a functional K+ 
channel when separated from its VSD domain(Santos et al., 2008). Second, regulatory 
modules, which control K+ channels, are also found in proteins with completely different 
enzymatic functions. A VSD displaying the hallmarks of those of Kv channels is 
connected to a soluble phosphatase in the sea squirt C. intestinalis Ci-VSP protein(Murata 
et al., 2005). Third, modularity also implies that domains of different classes of channels 
can be swapped. So far, attempts to exchange entire membrane modules between K+ 
channels have been unsuccessful leaving this third implication unfulfilled (Caprini et al., 
2001). Only small portions of the two domains, the “paddle” motif of the VSD and the P 
loop with part of the transmembrane domains of the pore, could be exchanged between 
K+ and Na+ channels (Lu et al., 2001; Alabi et al., 2007; Bosmans et al., 2008). From this 
it was concluded that membrane modules have coevolved so intimately in Kv proteins  
that it is impossible to exchange them entirely without loosing functionality of the 
chimeric channels.  
Here, we show that it is possible to obtain a voltage-gated channel in one step by 
fusing two full-length modules: the VSD of Ci-VSP and the PM of the viral K+ channel 
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Kcv (Plugge et al., 2000). These two membrane modules are evolutionary unrelated and 
there is not any “a priori” indication that they should be able to make a voltage-sensitive 
channel. The Ciona VSD regulates a soluble enzyme. Recent crystal structures capture 
this VSD in the “resting” and “active” conformations, revealing a ~5 Å translation of the 
S4 segment that agrees with the sliding helix gating model (Santoro et al., 1998). It was 
proposed that this movement underlies VSD control of Ci-VSP phosphatase, yet, it 
remains speculative if this type of conformational change between these states is 
sufficient for gating a K+ channel. The second component, the viral channel Kcv, is 
clearly not designed to be controlled by external stimuli, such as voltage. Apart from a 12 
amino acid long N terminus, the channel comprises only the bare PM and has neither 
additional membrane nor cytosolic domains (Plugge et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
Abbreviations used in this paper: Kv, voltage-gated potassium channel; VSD, voltage-sensing domain; 
Ci-VSP, Ciona intestinalis voltage-sensitive phosphatase; TM, transmembrane domain; WT, wild type. 
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Materials and Methods 
Chimaeric constructs 
All constructs were inserted into BamHI and XhoI restriction sites of pSGEM vector (a 
modified version of pGEM-HE). In vitro transcription was performed on linearized 
plasmids using T7 RNA polymerase (Promega) and cRNAs were injected (50 ng per 
oocyte) into Xenopus laevis oocytes, as previously reported6. Electrophysiological 
measurements were made 3–4 days after injection. Mutations were inserted by site-
directed mutagenesis (QuikChange® site-directed mutagenesis kit (Stratagene)) and 
confirmed by sequencing. Chimaeric constructs were generated by overlapping-PCR from 
Ci-VSP and PBCV-1 Kcv. KvSynth1 includes aa 1-239 of Ci-VSP and aa 1-94 of Kcv. All  
constructs reported  in Figure 3 were obtained with this procedure.  
Electrophysiological measurements 
Two-electrode voltage clamp experiments were performed as indicated previously6 using 
a GeneClamp 500 amplifier (Axon Instruments) and filtered at 5 kHz. Data acquisition 
and analysis were done using the pCLAMP8 software package (Axon Instruments). 
Electrodes were filled with 3M KCl and had a resistance of 0.2–0.8 M? in 50 mM KCl. 
The oocytes were perfused at room temperature (25–27 °C) at a rate of 2 ml/min with a 
bath solution containing 50 mM KCl (or NaCl), 1.8 mM CaCl2, 1 mM MgCl2, 5 mM 
Hepes, adjusted to pH 7.4 with KOH (or NaOH). Mannitol was used to adjust the 
osmolarity of the solution to 215 mosmol/l. BaCl2 diluted from 1 M stocks was added to 
the solution as indicated.  The standard clamp protocol consisted of steps from the 
holding voltage of ?20 mV to voltages in the range -100 mV to +100 mV; tail currents 
were measured at ?80 mV. Instantaneous and steady-state currents were sampled after 10 
ms and at the end of the voltage step respectively. 
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Results 
To test whether the voltage-dependent movement of the Ciona VSD is able to gate 
a channel, we created the fusion protein KvSynth1 by adding amino acids 1- 239 of Ci-VSP 
to the full length Kcv sequence (amino acid 1-94). The fusion protein and its individual 
components have been expressed in Xenopus oocytes and tested by two electrode voltage 
clamp. Control experiments show that VSD-injected oocytes (Figure 1A) generate small 
currents, not different from typical water-injected oocytes. Oocytes expressing Kcv alone 
(Figure 1B) show the typical K+ currents, previously characterized (Moroni et al., 2002; 
Gazzarrini et al., 2004; Kang et al., 2004; Gazzarrini et al., 2006; Abenavoli et al., 2009). 
The current/voltage relationship of Kcv is linear at moderate voltages. At extreme 
voltages the Ohmic behavior is lost due to a fast gating mechanism that occurs at the 
selectivity filter and results in a negative slope conductance (Abenavoli et al., 2009). 
KvSynth1 generates currents that are very different from those of its single components and 
shows the typical properties of a voltage-gated K+ channel (Figure 1C). Depolarizing 
voltages generate large time-dependent currents on top of a small instantaneous 
component. The corresponding steady-state current-voltage relationship (I/V) shows a 
strong outward rectification. To quantify the degree of rectification, we use the ratio of 
steady state currents at +60mV/-100mV (I+60mV/I-100mV). For KvSynth1 it is 13.3 ± 2 
(average of 6 oocytes); this ratio is 1 ± 0.1 in Kcv.  
KvSynth1 has the permeability properties of Kcv. Replacement of external K+ with Na+ 
shifts the reversal voltage of the fully activated KvSynth1 current by -80 mV ? 6 (s.d. n=3 
oocytes) (Fig. 2A) and reduces the outward current, another typical feature of Kcv 
(Plugge et al., 2000). The estimated relative permeability PNa/PK of 0.05 ? 0.01 closely 
resembles the value of 0.03 ? 0.01 previously reported for Kcv (Chatelain et al., 2009). 
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Another feature of Kcv that is preserved in KvSynth1 is the aforementioned negative slope 
conductance of the open channel, in this case already visible at ca. -100 mV (Figure 2A). 
Hence, the fast gating mechanism of Kcv is maintained in the synthetic channel pore. 
Supplementary Figure 1 summarizes other Kcv properties preserved in KvSynth1, including 
K+ selectivity, voltage-dependent barium block and biochemical evidence that the protein 
forms a functional tetramer. We also tested the pore mutation F305A that, as expected 
from our previous results with the Kcv mutant F66A (Plugge et al., 2000), completely 
abolished the current in KvSynth1 (Supplementary Figure 1D). ),. In summary, KvSynth1 
displays the pore properties of Kcv, such as selectivity, fast gating and overall pore 
architecture; these are not modified by the addition of the VSD. 
The new property introduced by the VSD is a strong voltage dependency of the currents. 
The voltage sensor closes the channel at negative potentials and opens it with a slow 
kinetics at voltages more positive than zero mV (t1/2 = 450 ? 74 ms at +60 mV (n=4 
oocytes), Figure 1C). The activation curve shown in Figure 2B was determined from the 
tail currents after subtraction of the instantaneous component (inset of Figure 2B). 
KvSynth1 has an apparent half activation voltage (V1/2) of +56 mV and channel opening is 
caused by the movement of the equivalent of about one electronic charge across the 
membrane (z = 0.92). These parameters strongly resemble those reported for the sensing 
currents of Ci-VSP, either with or without the phosphatase (Murata et al., 2005; Villalba-
Galea et al., 2008). The shallow voltage dependency of KvSynth1 with an estimated transfer 
of ~1 electronic charge is in agreement with the “one click” gating mechanism, recently 
proposed on the basis of the structural changes of the VSD7. To confirm that the VSD is 
responsible for the voltage-dependent properties of KvSynth1, we replaced two of the four 
arginines in the S4 segment, R229 and R232, with glutamines. In Ci-VSP this double 
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mutation eliminates the ‘sensing’ currents and generates a voltage-insensitive 
phosphatase (Murata et al., 2005; Murata and Okamura, 2007). In KvSynth1 the double 
mutation R229Q/R232Q results in a very small and quasi-Ohmic current (Supplementary 
Figure 1D); the mutated VSD has apparently lost its tight control on channel opening and 
voltage-dependency. Another interesting mutation that shifts the Q/V curve of Ci-VSP to 
the left by 46 mV, is the single neutralization of the gating charge R217 to Q (Villalba-
Galea et al., 2008). The same mutation in KvSynth1 resulted in a channel that is already 
more open at the holding voltage because the activation curve is shifted by 38 mV to the 
left (Figure 2C, D). Judging from the behavior of these mutants, we conclude that the 
properties of the VSD are transmitted to the gating of the pore. To examine further details 
of the causal interplay between VSD and channel gating, we tested whether KvSynth1 also 
reveals the mode-shift, which has been described for the sensor domain (Villalba-Galea et 
al., 2008). During a long-lasting depolarization, the voltage sensor enters a “relaxed” 
conformation in which the voltage–dependency is markedly shifted towards negative 
potentials. To test this, we measured the tail currents of KvSynth1 R217Q, after holding the 
same oocyte at two different pre-conditioning voltages, -100 mV and +40 mV. Figure 2E 
shows that the activation curve is shifted to more negative potentials when the membrane 
is maintained depolarized for long periods of time. The observed negative shift of about 
30 mV (n = 3 oocytes), matches quite well the direction and the amplitude of the shift 
reported for the VSD (Villalba-Galea et al., 2008). These data further confirm that the 
properties of the sensor are transmitted to the gating of the pore.  
Considerable evidence supports the role of the S4-S5 linker in Kv channels as the 
transducing element between sensor movement and pore gating (Long et al., 2005). In 
KvSynth1, the VSD is directly connected to Kcv, after removal of the 16 amino acid linker 
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that in Ci-VSP couples the VSD to the phosphatase (Figure 3A, B). Hence, the 12 aa long 
N terminus of Kcv acts here as the S4-S5 linker of Kv channels and transmits the 
conformational changes of the sensor to the pore. To study if and how the linker 
influences gating we varied its length and composition, by combining the N terminus of 
Kcv and the linker of the VSD, as shown in Figure 3B. All constructs produced functional 
channels, apart from that with the 28 aa linker that barely expressed and was not further 
analyzed. Figure 3C shows exemplary currents from constructs with 4, 6 and 20 aa linkers 
and their corresponding I/V relationships.  The first and most cogent observation is that 
there is a minimum linker length required for efficient control of the voltage sensor on the 
pore and that the transition is quite sharp.  The construct with 4 aa is quite similar to the 
original channel Kcv, while that with 6 aa shows the typical features of KvSynth1, 
rectification and slow kinetics.  Extending the linker up to 12 aa doesn’t change 
significantly the properties of KvSynth1 (data not shown), while trespassing this length 
results in a gradual disappearance of the properties, as evident from the construct with 20 
aa linker, showing a predominant instantaneous component and an increase in inward 
current (see also the corresponding I/V curves in Figure 3C). This trend is summarized in 
Figure 3D where we have plotted the degree of rectification (I+60mV/I-100mV) as a function 
of linker length, for all measurable constructs. Interestingly, rectification was not 
influenced by the amino acid composition because two constructs with a linker of the 
same length, 20 aa, but of different sequence (see 3B), gave the same result.   
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Discussion 
The addition of Ci-VSD to Kcv is sufficient and necessary to transform a voltage-
independent K+ channel into a Kv type outward rectifier. This finding has several 
corollaries. First of all it shows unambiguously that the shallow voltage dependency and 
the sliding helix-type movement of the S4 of Ciona VSD7 are sufficient to gate a channel 
pore and suggests that this might represent a common mechanism of voltage-dependent 
gating in ion channels.  
Second, it proves that electromechanical coupling between the VSD and the pore can 
occur even without co-evolution of the interacting surfaces of the two, an apparent 
requirement in Kv channels (Long et al., 2005; Lee et al., 2009). Another remarkable 
finding is that coupling is a function of linker length, with an apparent optimal length 
between 6 and 12 aa, and appears independent of its amino acid composition. We 
obtained functional coupling in KvSynth1 with completely unrelated sequences, such as the 
N terminus of Kcv and the C terminus of Ciona VSD (see Fig. 3).  
Our analysis is in agreement with the idea that a rigid connection, which is presumably 
provided by a short linker, favors the mechanical coupling between voltage sensor and 
pore. There is nevertheless a minimal linker length that has to be > 4aa to function.  
Third and last, because a primitive channel with poor control on gating can acquire 
sophisticated voltage regulation via fusion with a regulatory element from another source, 
it is possible that the appearance of Kv channels occurred in one evolutionary step, as 
previously suggested (Chanda and Bezanilla, 2008). 
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Figure legends 
Figure 1- The synthetic channel KvSynth1 is an outward rectifier.  
Top: cartoons of the individual components and of the fusion protein KvSynth1. (A) VSD is 
the voltage-sensing domain (aa 1-239) of Ci-VSP (2); S1-S4 indicate the 4 
transmembrane domains of the VSD. (B) Kcv is the full length (aa 1-94) viral K+ channel 
(6); TM1, TM2 and P indicate respectively the two transmembrane domains and the pore 
loop of Kcv. (C) KvSynth1 is the 333 aa fusion protein of VSD and Kcv. Middle: Currents 
recorded by TE-voltage clamp in oocytes injected with the three constructs. Dotted line 
indicates zero current level. Voltage protocol: Vh -20 mV, test voltages +100 to -100 mV 
(-200 mV for Kcv), tail -80 mV. Test pulse length is 8.5 s in A and C and 0.6 s in B. 
Bottom: corresponding steady state I/V relationships. All experiments were performed in 
50 mM [K+]out.  
 
Figure 2- Biophysical properties of KvSynth1. (A) KvSynth1 selects K+ over Na+. Current 
reversal potential recorded from the same oocyte was -20 mV in 50 mM [K+]out (?) and -
98 mV in 50 mM [Na+]out (?). Voltage protocol: pre-pulse voltage step at +60 mV 
followed by testing voltages from +60 to -180 mV. Arrowhead marks the point of data 
collection. (B) Voltage dependency of KvSynth1. Activation curve of KvSynth1 constructed 
from tail currents (inset) after subtracting the instantaneous current offset. Voltage 
protocol as in Figure 1C. Data sets (n=6) were jointly fitted to a two-state Boltzmann 
equation (dotted line) of the form y = (1 + ezF(V – V1/2) / RT) -1 where z is the effective 
charge, V1/2 is the half activation voltage, F, R and T have their usual thermodynamic 
meaning. Data were normalized to the extrapolated maximum current. Points represent 
mean ? s.e.m. V1/2 = 56 mV, z = 0.92. (C) Exemplary currents recorded from wt KvSynth1 
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(control) and its R217Q mutant. Traces have been normalized to the current value 
recorded at +60 mV. (D) Activation curve of the R217Q mutant (?) constructed as in B 
from 4 data sets: V1/2 = 18 mV, z = 1.1. The curve of the wt (dotted line) is re-plotted 
from B for comparison. (E) The activation of the R217Q mutant depends on the pre-
conditioning voltage. The same R217Q expressing oocyte was subjected to the following 
protocol: pre-conditioning (5 s) at either -100 mV or + 40 mV; test pulses (1.2 s) from -
120 mV to +30 mV. Tail currents (at -80 mV) are plotted for pre-conditioning at -100 mV 
(?) or at + 40 mV (?). The test pulses were kept short to maintain the effect of the 
preconditioning voltages; hence data in E do not reflect full activation of the channel. 
 
Figure 3- The length of the linker connecting the VSD to the pore affects the degree of 
rectification in KvSynth1 constructs. (A) Expanded view of the sequences of the two 
sequences that where variably combined to form the KvSynth1 linker. (B) List of linkers 
that have been tested in KvSynth1, their amino acid (aa) length and amino acid sequences 
(color coded as in panel A). (C) Exemplary current traces recorded from KvSynth1 
constructs with the 4, 6 and 20 aa linkers and their corresponding current-voltage 
relationships (color coded). (D) The degree of current rectification (I+60mV/I-100mV) is 
plotted as a function of linker length for all functional constructs. Data are mean ? s.e.m. 
(n?3). Experimental data (with the exclusion of the value corresponding to the construct 
with a 4 aa linker that loses the rectification) have been interpolated with a logistic 
function (black line) in which the lower asymptote was set to 1, corresponding to the 
value measured in Kcv that lacks rectification (dotted line). 
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 Supplementary Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1- K+ selectivity, barium block, tetramerization and effect of 
mutations in KvSynth1. 
(A) Nernst plot: KvSynth1 current reversal potential (Erev) plotted as a function of external 
K+ concentration (Lg[K+]out). Black line is the linear regression to mean Erev values 
(n=3). (B) Effect of Barium on KvSynth1 current. Steady-state currents recorded in: (?) 
control solution (50 mM K+) and (?) + 1mM BaCl2. The addition of barium blocks the 
inward current and affects the outward current, as previously reported for native Kcv 
channel (6). (C) Western blot analysis performed total protein extract from oocytes with a 
monoclonal antibody (8D6) that recognizes the tetramer of Kcv, but not the monomer. 
The expected MW of Kcv and KvSynth1 tetramers are 42,5 and 149 kDa, respectively. (D) 
Steady state current/voltage relationships of the single mutant F305A (?), the double 
mutant R229Q/R232Q (?) and the wt KvSynth1 (?). Points represent mean ? s.e.m. (n=6). 
Currents in B and D were recorded from a holding potential (Vh) of -20 mV to the 
indicated test voltages (8.5 s in B, 600 ms in D). 
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Background: HCN2 and HCN4 respond to cAMP, whereas HCN1 does not.
Results: The C-linker plus CNBD of HCN2 and HCN4 show cAMP-induced tetramerization, whereas that of HCN1 contains
prebound cAMP and is tetrameric.
Conclusion: HCN1 does not respond to the addition of cAMP because its CNBD contains cAMP already.
Significance: Tetramerization of the C terminus controls ligand gating in HCN channels.
Hyperpolarization-activated cyclic nucleotide-gated (HCN)
channels are dually activated by hyperpolarization and binding
of cAMP to their cyclic nucleotide binding domain (CNBD).
HCN isoforms respond differently to cAMP; binding of cAMP
shifts activation of HCN2 andHCN4 by 17mV but shifts that of
HCN1 by only 2–4 mV. To explain the peculiarity of HCN1, we
solved the crystal structures and performed a biochemical-bio-
physical characterization of the C-terminal domain (C-linker
plus CNBD) of the three isoforms. Our main finding is that
tetramerization of the C-terminal domain of HCN1 occurs at
basal cAMP concentrations, whereas those of HCN2 andHCN4
require cAMP saturating levels. Therefore, HCN1 responds less
markedly than HCN2 and HCN4 to cAMP increase because its
CNBD is already partly tetrameric. This is confirmed by voltage
clampexperiments showing that the right-shiftedpositionofV1⁄2
inHCN1 is correlatedwith its propensity to tetramerize in vitro.
These data underscore that ligand-induced CNBD tetrameriza-
tion removes tonic inhibition from the pore of HCN channels.
Hyperpolarization-activated cyclic nucleotide-gated (HCN)2
channels underlie the If/Ih cation currents that control pace-
maker activity in the heart and brain (1–3). HCN channels
belong to the superfamily of the six-transmembrane domain
segment voltage-gated K! channels and are dually activated by
membrane hyperpolarization and binding of cAMP to their
cyclic nucleotide binding domain (CNBD) (4–6). Increase in
the cytosolic cAMP concentration shifts the channel voltage
dependence to more positive potentials, thereby increasing the
open probability and current at a given voltage. In this respect,
the three most studied isoforms, HCN1, HCN2, and HCN4,
behave differently. HCN2 and HCN4 respond to saturating
cAMP levels by shifting the activation curve of !17 mV,
whereas HCN1 only shifts it by !4 mV (7). Interestingly, the
behavior of HCN1 seems not to be due to a lower affinity of this
isoform for cAMP because dose-response curves obtained in
patch clamp recordings in inside-out configuration indicate
similar nanomolar affinity for HCN1 and HCN2 activation (7,
8).
The current understanding of ligand-induced gating inHCN
channels is that cAMP binding releases the tonic inhibition
exerted by the cytoplasmic CNBD on the channel pore. This
mechanism probably involves cAMP-induced tetramerization
of the CNBD and is supported by two lines of evidence. On one
side, removal of the cytosolic domain, by enzymatic digestion in
the native If channels (9) or by gene manipulation in HCN
clones (10),mimics the action of cAMPand shifts the activation
curve of the channels to more depolarized potentials. On the
other side, the addition of saturating cAMP concentrations
promotes the tetramerization of the isolated cytosolic fragment
(consisting of the CNBD and the C-linker) of HCN2 andHCN4
in solution (11, 12). Furthermore, it has been shown in HCN2
that promotion of tetramerization induced by a tripeptide
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mutation in the C-linker facilitated channel opening in the
absence of cAMP (13).
With this background, we have focused our attention on
HCN1 in order to explain its peculiar properties that include,
besides aweak response to cAMP, also a right-shifted activation
curve, when compared with the other isoforms (7, 8, 10), indi-
cating that this isoformmight partially lack the inhibition of the
CNBD. To this end, we have solved the crystal structures of the
cytosolic fragment (C-linker plus CNBD) of HCN1, HCN2, and
HCN4 and compared them. Furthermore, we have systemati-
cally analyzed the ligand binding and ligand-induced tetramer-
ization properties of the three proteins in solution. Our results
show that the C-terminal fragment of HCN1 differs from those
of HCN2 andHCN4 because it forms tetramers already at basal
cAMP concentration, whereas tetramerization of the C-termi-
nal domain of HCN2 andHCN4 requires saturating cAMP lev-
els. This finding explains the modest response of HCN1 to the
addition of cAMP in vivo and, in general, offers an experimental
proof to the leading hypothesis that cAMP-induced tetramer-
ization of theC-terminal domain ofHCNchannels removes the
inhibition exerted by this domain on the pore gating.
EXPERIMENTAL PROCEDURES
Protein Preparation—The cDNA fragments comprised the
C-linker and CNBD (CB) and encoded the following residues:
470–672 (humanHCN2CB), 521–723 (humanHCN4CB), 390–
592 (mouse HCN1CB), and 441–592 (#C-linker HCN1CNBD).
The fragments were cloned into a modified pET-24b down-
streamof a doubleHis6-maltose-binding protein (MBP) tag and
transformed into Escherichia coli Rosetta strain. Cells were
grown at 37 °C in Luria broth to 0.6 A600 and induced with 0.4
mM isopropyl 1-thio-!-D-galactopyranoside overnight at 20 °C.
The cells were collected by centrifugation and resuspended in
ice-cold lysis buffer (30 mM Hepes, pH 7.4, 500 mM NaCl, 10%
glycerol, 1 mM !-mercaptoethanol) with the addition of 10
"g/ml DNase, 0.25 mg/ml lysozyme, 100 "M phenylmethylsul-
fonyl fluoride, 5 "M leupeptin, and 1 "M pepstatin. The cells
were sonicated on ice 12 times for 20 s each, and the lysate was
cleared by centrifugation. The proteins were purified by affinity
chromatography on Ni2!-NTA and eluted in lysis buffer plus
300 mM imidazole. The His6-MBP was removed by HRV3C
cleavage overnight at 4 °C. The cleavage reaction was loaded
onto an amylose resin (New England Biolabs), and the flow-
through was collected and loaded onto a HiLoad 16/60 Super-
dex 200 prep grade size exclusion column (GEHealthcare) that
was equilibrated with lysis buffer. Analysis presented in Fig. 3
and Fig. 5 was performed with Superdex 200 5/150 GL (GE
Healthcare). Protein concentration was 1.5 mg/ml. Buffer con-
tained 100mMNaCl, 20mMHepes, pH7.0, 10% glycerol with or
without cAMP.
Fluorescence Polarization—Thedirect fluorescence polariza-
tion (FP) assay was performed following in principle the proce-
dure from Moll et al. (14). 8-Fluo-cAMP and 8-Fluo-cGMP
were purchased from the Biolog Life Science Institute (Bremen,
Germany). Fine chemicals (research grade) were purchased
from Sigma. The measurements were performed in 150 mM
NaCl, 20 mM MOPS, 0.005% (v/v) CHAPS, pH 7.0, using the
FusionTM #-FP microtiter plate reader at room temperature in
a 384-wellmicrotiter plate (PerkinElmer,Optiplate, black). The
protein concentration was varied (from 50 "M to 12 pM), and
the concentration of 8-Fluo-cAMP/8-Fluo-cGMP was fixed at
1 nM. The FP signal was detected for 2 s at excitation of 485 nm
and emission FP filter of 535 nm with a photomultiplier tube
voltage of 1,100. Data were analyzed with GraphPad Prism 5.03
(GraphPad Software, San Diego, CA) by plotting the FP signal
in millipolarization units (mPol) against the logarithm of the
HCN concentration.
Isothermal Titration Calorimetry—Measurements were car-
ried out at 25 °C using an iTC200 microcalorimeter (MicroCal,
GE Healthcare). The volume of sample cell was 0.2 ml; the ref-
erence cell contained water. The proteins were extensively dia-
lyzed against PBS plus 10% glycerol, and the same buffer was
used to dissolve cAMP. The proteins (11–75 "M) were titrated
with cAMP (250–900 "M) using injection volumes of 1–2 "l.
Calorimetric data were analyzed with Origin software (version
7,MicroCal), using equations described for the single-site bind-
ing model (15).
Surface Plasmon Resonance Measurements—Protein/nucle-
otide interactions were monitored as solution competition
experiments and were performed using a Biacore 3000 instru-
ment (Biacore GE Healthcare) at 20 °C.
A carboxymethylated sensor chip surface (CM5, research
grade, Biacore GE Healthcare) was activated for covalent cou-
pling of 8-AHA-cAMP as described previously (16). Running
buffer was PBS, pH 7.4, plus 0.005% (v/v) surfactant P20. Pro-
teins (100 nM) were preincubated with varying concentrations
of free cAMP and injected over the 8-AHA-cAMP surface. Sur-
face plasmon resonance (SPR) signals indicate binding of the
respective proteins to the cAMP analog 8-AHA-cAMP cova-
lently linked to the sensor chip. The association was monitored
for 3 min, and the binding signal was collected at the end of the
association phase. The resulting binding signals were plotted
against the logarithm of the free cAMP concentration, and the
EC50 values were calculated form the dose-response curve.
Crystallization—Crystallization trials were set up in 96-well
sitting drop plates (Greiner) using the Orxy 8.0 crystallization
robot (Douglas Instruments) and stored at 4 °C. Crystals of the
mHCN1-cAMP complex (protein concentration 10 mg/ml, 5
mM cAMP) were grown by vapor diffusion, using as a precipi-
tant solution 20–22%PEG3350, 400mM sodiumacetate buffer,
pH5.0. Crystals usually grew in 2weeks andwere cryoprotected
with the same crystallization well solution supplemented with
30% glycerol prior to cryocooling in liquid nitrogen. A full data
set was collected to 2.9 Å resolution using synchrotron radia-
tion (ID29 beamline, ESRF, Grenoble, France). Crystals of the
human HCN2-cAMP complex (protein concentration 10–13
mg/ml, 5 mM cAMP) were grown by vapor diffusion, using as a
precipitant solution 20% PEG 8000, 500 mM NaCl, 100 mM cit-
rate buffer, pH 4.6, 10% glycerol. A full data set was collected to
2.3 Å resolution (ID23-2 beamline, ESRF, Grenoble, France).
Crystals of the humanHCN4-cAMP complex (protein concen-
tration 10 mg/ml, 5 mM cAMP) were grown by vapor diffusion
using as a precipitant solution 25% PEG 3350, 400 mM sodium
acetate buffer, pH 5.0 (with/without 500 mM dibasic ammo-
nium phosphate). A full data set was collected to 2.5 Å resolu-
tion (ID29 beamline, ESRF, Grenoble, France). Raw data were
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processed with Mosflm (17) and Scala (18), and the structures
were solved by molecular replacement using the programMol-
Rep (19). The crystal structure ofmouseHCN2 in complexwith
cAMP (11) (Protein Data Bank entry 1Q43) was used as search
model. To avoid model bias, the bound cAMP was removed
from the search model, and the side chains were truncated to
Ala in cases of mismatch between the amino acid sequences.
Several cycles of manual rebuilding, using the program COOT
(20), and refinement, using the program REFMAC (21) (rigid
body and restrained refinement), were carried out to improve
the electron density map, and the side chains omitted in the
search model were rebuilt into the electron density.
The final R-factor/R-free for HCN1-cAMP, HCN2-cAMP,
and HCN4-cAMP are 20.5%/27.5%, 20.2%/27.1%, and 19.3%/
27.7%, respectively (supplemental Table I). Residue 586 of
HCN4-cAMP has been modeled and refined as S-hydroxycys-
teine (probably induced by x-ray oxidation). The program Pro-
check (22) was used to assess protein stereochemical quality.
The program PISA (23) was used to identify and analyze the
quaternary assemblies. Atomic coordinates and structure fac-
tors have been depositedwith the ProteinData Bank, with entry
codes 3U0Z, 3U10, and 3U11 for HCN1-cAMP, HCN2-cAMP,
and HCN4-cAMP, respectively.
Analytical Ultracentrifugation—Sedimentation Velocity
experiments were performed at 20 °C using a Optima XL-I
Ultracentrifuge (Beckman Coulter) with an An50 Ti rotor at a
rotor speed of 50,000 rpm. Data were acquired by monitoring
absorbance at 280 nm through sapphire cell windows, in Epon
sectors. Proteins (2.5 mg/ml) were run at 100 "M, and the
related gel filtration buffer was used as a blank (20 mM Hepes,
pH 7.0, 150 mM NaCl, 10% glycerol). cAMP at a concentration
of 0.3 mM was added directly to the protein and reference solu-
tions. Data were analyzed with the software SEDFIT (24) to
determine the sedimentation coefficients of the proteins in
solution. Solvent density (1.028 g/ml), partial specific volume
(0.7354 ml/g), and viscosity (0.013284 g/s/cm) were calculated
using the SEDNTERP program (available on the World Wide
Web). The oligomeric states of the proteinswere determined by
comparing the sedimentation coefficients from SEDFIT with
those calculated using the crystallographic coordinates and the
program HYDROPRO (25).
Dynamic Light Scattering—Experiments were conducted
using a Protein Solutions DynaPro 99 instrument with a
DynaProMSTC200 microsampler (Protein Solutions, Charlot-
tesville, VA). Protein concentration was 1 mg/ml. Buffer con-
tained 20mMHepes, pH7.0, 150mMNaCl, 10% glycerol with or
without 2.5 mM cAMP. Acquisition was performed at 10 °C
with Dynamics 5, 30–50 scans, 30 s/scan. Data analysis was
performed with Dynamics 6 software.
Determination of cAMP Content—cAMP was released by
boiling the protein sample ($1 mg) in 100 "l of lysis buffer for
2 min. The boiled sample was centrifuged at maximum speed
for 10 min at room temperature, and the supernatant was col-
lected and added with 900 "l of 5 mM ammonium bicarbonate.
The sample was loaded onto an anion exchange chromatogra-
phy column (HiTrapQ (1ml), GEHealthcare), previously equil-
ibrated with 5 mM ammonium bicarbonate. Unbound mole-
cules were washed out with 7 ml of 5 mM ammonium
bicarbonate. The cAMP was eluted with a linear gradient of
ammonium bicarbonate (5–1000 mM) in 20 column volumes.
Electrophysiology—Site-directed mutagenesis on pGHE::
mHCN1was performed using theQuikChangemutagenesis kit
(Stratagene). All of the constructs were linearized and tran-
scribed into cRNA using T7 polymerase (T7 Riboprobe" sys-
tem, Promega). Oocyte preparation and cRNA transcription
were performed according to standard procedures as reported
previously (26). Oocytes were injected with 50 nl of cRNA solu-
tion each, at a concentration of 0.5 "g/"l. Two-electrode volt-
age clamp recordings were performed 2 days after cRNA injec-
tion using a GeneClamp 500 amplifier (Axon Instruments) and
digitized at 50 kHz with a Digidata 1200 (Axon Instruments).
Data acquisition and analysis were done using the pCLAMP8
software package (Axon Instruments). Microelectrodes filled
with 3 M KCl had resistances of 0.5–2.0 megaohms. Oocytes
were bathed in extracellular solution containing 98 mM KCl, 2
mM NaCl, 5 mM HEPES, pH 7.5, 1.8 mM CaCl2, and 1 mM
MgCl2. Three-second-long voltage steps were applied in
10-mV increments from a holding potential of %30 mV. Peak
tail current amplitudes were measured at %40 mV, and tail
current I-V curves were fitted using the Boltzmann equation,
I(V)& A1! A2/(1! exp((V% V1⁄2)/s)).
RESULTS
cAMP Binding Affinity Measurements—We have prepared
three constructs, hereafter termed HCN1CB, HCN2CB, and
HCN4CB, comprising the C-linker and the CNBD domains of
mouse HCN1, human HCN2, and human HCN4, respectively.
The three constructs differ by 26 substitutions in total, 14 of
which occur in HCN1CB (supplemental Fig. 1). The purified
proteins were tested for cyclic nucleotide binding with three
different techniques: FP, SPR, and isothermal titration calorim-
etry (ITC). The three proteins showed similar binding affinities
when tested with the same technique (Table 1), but different
techniques gave quite different absolute values (12). In FP
measurements, all three proteins bind the 8-Fluo-cAMP analog
in the nanomolar range (Table 1). Notably, the highest affinities
weremeasuredwith themaltose-binding protein fused at theN
terminus of the HCN proteins (MBP-HCNCB). Fig. 1 shows
exemplary curves in which KD values of 39.7, 82.0, and 39.2 nM
were calculated for MBP-HCN1, MBP-HCN2, and MBP-
HCN4 constructs, respectively. These results are remarkably
similar to the K1⁄2 values obtained in patch clamp experiments:
60 and 100 nM for HCN1 and HCN2, respectively (8).
Themeasured affinity of theHCNproteins for 8-Fluo-cGMP
was significantly lower than that for 8-Fluo-cAMP, at least for
HCN2 and HCN4, but still in the nanomolar range. Notably,
patch experiments had previously reported micromolar K1⁄2 for
HCN2 (11, 27). This observation suggests that the higher K1⁄2
values for cGMP might be related to a lower efficacy of this
ligand in promoting gating.
When we measured binding with other techniques, we
obtained 10 times lower affinities. Binding of cAMP by ITC
showed micromolar affinity with and without the MBP con-
structs: for MBP-HCN2CB, KD & 3.06 ' 0.7 "M; for MBP-
HCN4CB,KD& 0.97' 0.7"M; and forHCN2CB,KD& 3.6' 1.3
"M (Table 1 and supplemental Fig. 2). For unclear reasons, we
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were not able to record binding with the HCN1CB constructs.
Micromolar binding was also measured by SPR with immobi-
lized 8-AHA-cAMP in a solution competition experiment. In
this case, the signal obtained with HCN1CB was low but meas-
urable. The calculated EC50 values where roughly the same for
the three proteins: 5' 1, 10' 4, and 11' 2 "M for HCN1CB,
HCN2CB, and HCN4CB, respectively.
Altogether, the binding data show no dramatic difference in
the binding affinities of the three proteins. Notably, different
techniques yielded different results; the most plausible expla-
nation is that different cAMP and cGMP analogs indeed have
different affinities for the proteins, as reported for HCN2 (28).
But these results are not necessarily due to technical reasons.
They may highlight a high and a low affinity state of the same
protein. The low to absent signal of HCN1 observed in two
cases (SPR and ITC measurements) highlights a difference
from HCN2 and HCN4, probably in the fraction of protein
available for binding. We did not observe a systematic differ-
ence in binding due to the presence of theMBP (e.g. see the ITC
results for HCN2 in Table 1).
CNBD Structural Comparison—We next determined the
crystal structures of HCN1CB, HCN2CB, and HCN4CB (at 2.9,
2.3, and 2.5 Å resolutions, respectively) (supplemental Table I).
Fig. 2A shows a top view of the three-dimensional structure of
mouse HCN1CB. It crystallized as a tetramer in the presence of
5 mM cAMP, as shown previously for mouse HCN2 (11) and,
more recently, for human HCN4 (12). Fig. 2B shows the ter-
tiary structure of the HCN1CB protomer, with the seven
#-helices of the C-linker (A"–F") in gray and the CNBD,
composed of four #-helices (A, P, B, and C) and eight
!-sheets (numbered 1–8) in gold. Fig. 2C shows a side view of
the tetramer, highlighting the contacts provided by the
C-linker, where the A" and B" helices contact the C" and D"
of the neighboring subunit. The cAMP binding mode (with
the cAMP molecule adopting the anti-conformation) and
the most relevant protein-ligand interactions are conserved
in HCN1CB, HCN2CB, and HCN4CB (Fig. 2D and supplemen-
tal Table II). The tertiary structure of HCN1CB superimposes
well with those of HCN2CB (average root mean square devi-
ation of 0.85 Å over 198 C# atoms) and of HCN4CB (average
root mean square deviation of 1.05 Å over 197 C# atoms)
(Fig. 2E). The only deviations of the C# backbones emerge
for two short regions located at the C-linker and at the loop
between strands !4 and !5 (facing the cAMP binding pocket,
circled in Fig. 2E). Such discrepancies are not surprising
because most of the residue substitutions of HCN1CB cluster
in these regions (supplemental Fig. 1). Analysis of the sub-
unit interfaces reveals that all HCN structures share similar
TABLE 1
Comparison of binding constants for cyclic nucleotide binding to the C termini of HCN proteins (HCNCB) derived from FP, SPR, and ITC
measurements
KD (from FP)! S.E.a
EC50 (from SPR)! S.D. for cAMP KD (from ITC)! S.D. for cAMP8-Fluo-cAMP 8-Fluo-cGMP
nM "M "M
MBP-HCN1CB 116' 26 (n& 4) 208' 51 (n& 5) NDb Not measurable
MBP-HCN2CB 115' 18 (n& 4) 286' 34c (n& 5) ND 3.06' 0.7 (n& 9)
MBP-HCN4CB 111' 36 (n& 4) 414' 56d (n& 3) ND 0.97' 0.7 (n& 4)
HCN1CB 382' 87 (n& 4) 386' 76 (n& 3) 5' 1e (n& 5) Not measurable
HCN2CB 606' 219 (n& 3) 752' 236 (n& 3) 10' 4 (n& 3) 3.6' 1.3 (n& 3)
HCN4CB 167' 36 (n& 4) 694' 121d (n& 4) 11' 2 (n& 3) ND
HCN1CB #C-linker ND ND 5' 2e (n& 3) ND
HCN1CB G510S/S515G/S516N ND ND 7.3' 1.6e (n& 3) ND
a FP experiments were in duplicate or triplicate.
bND, not determined.
cMean p( 0.05; values are significantly different from that of 8-Fluo-cAMP (analyzed by paired t test, p value two-tailed, confidence interval 99%, GraphPad Prism version
5.03).
dMean p( 0.01; values are significantly different from that of 8-Fluo-cAMP (analyzed by paired t test, p value two-tailed, confidence interval 99%, GraphPad Prism version
5.03).
e Protein concentration was 500 nM instead of 100 nM.
FIGURE 1. Determination of the dissociation constant KD for 8-Fluo-cAMP (black square) and 8-Fluo-cGMP (gray circle) to MBP-tagged HCN1CB (A),
HCN2CB (B), and HCN4CB (C) using fluorescence polarization. KD values for 8-Fluo-cAMP and 8-Fluo-cGMP are as follows: for MBP-HCN1CB, KD& 40 and 60
nM; for MBP-HCN2CB, KD& 82 and 209 nM; for MBP-HCN4CB, KD& 40 nM and 135 nM.
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buried surface areas between adjacent subunits (average of
1085 Å2) and mostly conserved polar interactions.
In conclusion, the comparative structural analysis of cAMP-
bound HCN proteins (i.e. the end products of cAMP binding
and tetramerization processes) did not highlight systematic
structural differences that would group HCN1CB separately
fromHCN2CB andHCN4CB. This prompted us to look for pos-
sible differences between HCN1CB and the other isoforms in
the apo-form, a state in which HCN1CB diverges substantially
from the other two, as for cAMP-induced gating in vivo.
CNBD Oligomerization Propensity—To test this hypothesis,
a solution experimental approach was undertaken on the apo-
FIGURE 2.Crystal structure of the soluble portion CB (C-linker plus CNBD) of HCN1bound to cAMP. A, HCN1CB tetramer viewed parallel to the 4-fold axis.
Each subunit is shown in a different color. B, the protomer of HCN1CB with cAMP. The C-linker, helices A"–F", is in gray; the CNBD,!-sheets 1–8 and helices A, B,
P, and C, is in gold. C, subunit-subunit interactions mediated in the tetramer by the C-linker; helices A" and B" form a helix-turn-helix motif that interacts with
the helix-turn-helix motif formed by the C" and D" helices of the neighboring subunit. The C-linker of one monomer (red) contacts two other subunits in the
tetramer (green and orange). Cylinders and arrows represent helices and strands, respectively. D, from left to right, cAMP binding site of HCN1CB, HCN2CB, and
HCN4CB, showing hydrogen bonds and salt bridges that stabilize the cAMPmolecule. The binding amino acids are conserved among the three HCN isoforms.
In particular, six polar contacts are strictly preserved between the same atoms (see supplemental Table II for the list of interactions). In addition, the residue
Cys-531 (HCN1) makes a salt bridge (not present in the other two isoforms) between its nitrogen and the O1P of the cAMP, stabilizing the cyclic nucleotide
inside the binding pocket. Another stabilizing element is the polar contact between residue Arg-582 (Arg-659 in HCN2 andArg-632 in HCN4) and the atomN1
of the cAMP. The same atom contacts residue Arg-579, fundamental for the affinity for the cNMP (27). Also visible in our HCN2 structure are two more polar
contacts (not reported in Ref. 11) between the atoms O2* andO2P (cAMP) and the nitrogen atoms of the residues Cys-611 and Gly-608, completing the range
of strictly preserved amino acids mentioned above. E, differences in the structures highlighted by the superimposition of HCN1CB (red), HCN2CB (blue), and
HCN4CB (green). The!4-!5 loop at the entrance of the cAMP binding site in the CNBD is circled. F, alignment of the amino acid sequences of the three proteins
in the circled region. Secondary structures are indicated by the blue/red bars. Residues identical in HCN1 and HCN2 (black) but different in HCN1 (red) are
highlighted. The conserved arginine, Arg-538 in HCN1, important for cAMP binding, is indicated by an arrow.
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forms of the three constructs. Fig. 3 summarizes three inde-
pendent lines of evidence highlighting that HCN1CB has differ-
ent oligomerization properties from the others: HCN1CB is
present in a tetrameric form already in the absence of added
cAMP, whereas HCN2CB and HCN4CB form tetramers only in
its presence. In size exclusion chromatography, HCN2CB and
HCN4CB elute as a single peak (Fig. 3, B and C, solid line),
whereas HCN1CB elution shows an additional peak at higher
molecular weight (Fig. 3A, solid line). The higher molecular
weight peak appears in HCN2CB and HCN4CB only upon the
addition of cAMP (Fig. 3, A–C, dashed red lines). Sedimenta-
tion velocity analytical ultracentrifugation studies assign a
proper size to the two forms (Fig. 3, D–F, and supplemental
Table III). In the absence of added cAMP, HCN2CB and
HCN4CBweremainly identified asmonomers, with only a small
amount of dimeric component (Fig. 3, E and F, solid line). In
contrast, HCN1CB exists as a mixture of monomers, dimers,
and tetramers (Fig. 3D, solid line). These oligomeric states are
observed for HCN2CB and HCN4CB only after adding saturat-
ing amounts of cAMP (Fig. 3, D–F, dashed red line). Interest-
ingly, the equilibrium between monomer/dimer and tetramer
observed in the HCN1CB protein depends on the ionic strength
of the solution. Fig. 3G shows the effect of increasing salt con-
centration, from 100 to 400 mM, on the elution profile of
FIGURE 3.HCN1CB tetramerizes in the absence of added cAMP. A–C, size exclusion chromatography profiles of HCN1CB (black), HCN2CB (blue), and HCN4CB
(green) proteins in the absence (solid line) and in the presence (dashed red line) of 1 mM cAMP; D–F, distribution of the sedimentation coefficient (c(s)), as
calculated from sedimentation velocity experiments for HCN1CB, HCN2CB, andHCN4CB in the absence (solid line) and in the presence (dashed red line) of 0.3mM
cAMP; black arrowheads indicate from left to right the theoretical values for monomer, dimer, and tetramer (supplemental Table III); G, size exclusion chroma-
tography profiles of HCN1CB obtained in the absence of cAMP at increasing NaCl concentration: 100, 150, 200, 300, and 400 mM. The absorbance values are
normalized to the peak at 2.2 ml of elution volume. H, differential curves showing the cAMP-induced change in protein radius estimated by dynamic light
scattering. Curveswereobtainedby fitting individual dynamic light scattering spectra in thepresence andabsenceof 2.5mMcAMPwith singleGaussians. After
normalizing the fitted curves to the same ordinate, the difference spectra were obtained by subtracting the curves in the presence from those in the absence
of cAMP. Each pair includes$4 data sets.
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HCN1CB. The disappearance of the tetrameric form of the pro-
tein implies an electrostatic nature for the stabilizing interac-
tions. This is strengthened by the observation that, in the
tetramer of HCN1CB, all 14 substitutions that distinguish this
isoform from the other two are exposed to the solvent, and five
of them (Ile-432, Asn-437, Asp-444, Ala-496, and Val-497) are
at the interface between monomers (not shown).
Finally, dynamic light scattering analysis indicates that, in the
absence of added cAMP, HCN2CB and HCN4CB are mainly
dimers, whereas HCN1CB is a mixture of dimers and tetramers.
The addition of cAMP promotes the full tetramerization of
HCN2CB andHCN4CB as well as the residual tetramerization of
HCN1CB (supplemental Table IV). The differential signal in the
dynamic light scattering peaks, which is due to the addition of
cAMP, is illustrated in Fig. 3H, indicating the presence of tetra-
meric HCN1CB protein in the absence of added cAMP.
cAMPRetention after Purification—On the basis of the above
reported evidence, a clear and systematic difference emerges
between HCN1CB and the other two proteins; whereas
HCN2CB andHCN4CB form tetramers only after the addition of
saturating concentrations of cAMP, HCN1CB is found as a
tetramer already without the addition of exogenous cAMP.
This raises the question ofwhetherHCN1CB has a high propen-
sity to tetramerize in the apo-state or if this behavior is due to
some tightly prebound cAMP. We then analyzed the endoge-
nous cAMP content associated with the protein after purifica-
tion. As a negative control, we prepared the mutant protein
R538E HCN1CB. Mutation of this invariant amino acid (Arg-
591 in HCN2 and Arg-669 in HCN4) that interacts with the
exocyclic oxygen of the cAMPphosphate (29) reduces the affin-
ity of HCN CNBD for the ligand by more than 3 orders of
magnitude (7, 27, 30). Fig. 4A shows that HCN1CB contains a
significantly higher amount of endogenous cAMP than
HCN2CB and HCN4CB. The measured molar ratio (protein/
cAMP) in HCN1CB is 6. In contrast, this ratio is 24 in HCN4CB
and 50 in HCN2CB. The value found in the negative control
HCN1CB R538E is 40 (Table 2). Furthermore, separate analysis
of the two forms of HCN1CB, monomer/dimer and tetramer,
showed that almost all cAMP is in the tetrameric form, where
we found a protein/cAMP ratio of 2 (Fig. 4B and Table 2). From
these experiments, we must conclude that the tetrameric, but
not the monomeric/dimeric, form of HCN1CB contains endog-
enous cAMPand binds it with high affinity because the ligand is
not released during the purification procedure. Altogether our
data confirm that cAMP binding to CNBD promotes tetramer-
ization of the C-terminal fragment (11, 12) and suggest that
cAMP binds with high affinity to the HCN1CB tetramer, result-
ing in ligand trapping. We further tackled this point by check-
ing 1) the tetramer formation of an HCN1 mutant with a
reduced affinity for cAMPand 2) the cAMPcontent in a protein
with altered tetramerization properties.
Point one was addressed by testing the elution profile in size
exclusion chromatography of the R538E mutant that, as previ-
ously mentioned, has a decreased affinity for cAMP. As shown
in Fig. 5A, R538E protein elutes as a monomer/dimer and does
not show the tetramer peak found in thewild type. As expected,
themutant also does not tetramerize upon the addition of 1mM
cAMP.
In regard to point two, in order to prevent tetramerization,
wemodified theC-linker, because it establishes extensive inter-
actions thatmediate the assembly of the four subunits (Fig. 2C).
We deleted the first three helices (A", B", and C") and tested the
resulting protein fragment, #C-linker HCN1CB, for tetramer-
ization and cAMPbinding. For control, we have also performed
the same deletion in HCN2CB and HCN4CB. We found that
#C-linker HCN1CB does not show the tetramer peak in size
exclusion chromatography and that addition of cAMP does not
induce its tetramerization (Fig. 5, B and C, and supplemental
Table IV). The same behavior was found for #C-linker
HCN2CB and #C-linker HCN4CB (data not shown). It is worth
noting that#C-linkerHCN1CB is still able to dimerize, as deter-
mined by dynamic light scattering (supplemental Table IV).
FIGURE 4. Quantification of the cAMP molecules released by the HCN proteins. Cyclic AMP content was estimated by the absorbance at % & 254 nm
(calibration curve shown in supplemental Fig. 3). A, absorbance profiles of cAMP released by the three HCNCB proteins after boiling (for experimental details,
see “Experimental Procedures”).B, comparisonbetween the cAMPcontentof themonomer/dimer andof the tetramer formofHCN1CB.C, comparisonbetween
the cAMP content of the WT HCN1CB and the HCN1 #C-linker protein (see Table 2 for molar ratios).
TABLE 2
Cyclic AMP content in purified HCNCB proteins expressed as molar
ratio (protein/cAMP)
Molar ratio (protein/cAMP) n
HCN1CB 6' 2 5
HCN2CB 49.5' 8.5 4
HCN4CB 24' 5 3
HCN1CB monomer/dimer 17' 2.7 3
HCN1CB tetramer 2.2' 0.36 3
HCN1CB #C-linker 25' 3 3
HCN1CB R538E 40 1
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The results of these experiments show that tetrameric assembly
requires the presence of an intact C-linker region, in agreement
with the proposed role of the C-linker in oligomerization (11,
13).We then tested if this construct could trap cAMP. Interest-
ingly, #C-linker HCN1 has a very low content of cAMP (pro-
tein/cAMP ratio & 25) (Fig. 4C and Table 2), showing that an
intact C-linker is needed to establish the high affinity state,
which traps cAMP in the CNBD. It is worth noting that this
construct shows micromolar affinity for cAMP by SPR (Table
1), indicating that this affinity value corresponds to that of the
low affinity state. The question is why HCN1CB behaves differ-
ently from the other two isoforms. To answer this question, we
have reconsidered the divergence in the !4-!5 loop found in
the holo-structures because it was recently reported that this
linkermodulates binding inHCN4 (12). Three residues that are
conserved in the !4-!5 region of HCN2 and HCN4 but not in
HCN1 have been tested by performing the followingmutations
in HCN1: the single mutation G510S, the double mutation
S515G/S516N, and the triple mutation G510S/S515G/S516N.
We tested their impact on cAMP binding to HCN1CB and on
the electrophysiological properties of the full-length channel
expressed in Xenopus oocytes. None of the mutations changed
the binding properties of HCN1CB or the tetramerization
behavior in gel filtration and the cAMP content of the protein
(data not shown). Thus, we have to conclude that the !4-!5
loop does not determine the peculiar biochemical properties of
HCN1CB. Similar results were obtained by measuring, in intact
oocytes, the activation curves ofwild type andmutant channels.
Table 3 reports the calculated values for half-activation voltage
ofWTHCN1 and the mutants. None of the mutations affected
this parameter. We further extended our analysis to the !5
strand and tested the mutation M519T, previously reported to
affectK1⁄2 inHCN2without affecting the binding (12). Again, we
observed no effect either on V1⁄2 (Table 3) or on binding (not
shown). As controls for the voltage clamp experiments, we used
the wild type HCN2 and the low affinity mutant HCN1 R538E.
Both channels showed an equally left-shifted V1⁄2 (%76 mV)
when compared with HCN1, as reported previously (7). From
these experiments, we conclude that the right-shifted position
of theV1⁄2 of HCN1 is correlated with its property of eluting as a
tetramer in vitro. This is in line with the finding that the two
controls, HCN2 and HCN1 R538E, that do not form tetramers,
are left-shifted in vivo.
DISCUSSION
In this paper, we have addressed the behavior of the pace-
maker channel isoform HCN1, which, unlike HCN2 and
HCN4, shows a right-shifted activation curve and responds
weakly to saturating cAMP levels in vivo. According to the cur-
rent view, this behavior is reminiscent of a lack of inhibition by
the CNBD. To test this hypothesis, we have solved the crystal
structure of the isolated C-terminal domain ofHCN1 and com-
pared it with those of HCN2 and HCN4; furthermore, we have
tested their biophysical and biochemical properties in vitro and
validated them by electrophysiology.
In the cAMP-bound form, all threeHCN isoforms show sim-
ilar tertiary and quaternary structures. The holoproteins are
tetrameric, with the C-linkers mediating the “elbow on shoul-
der” assembly of the four subunits (11). A deviation of the C#
backbones emerges only in the !4-!5 loop, where the substitu-
tions among the three proteins are clustered (Fig. 2).
This loop is in proximity to the ligand binding pocket and,
therefore, could potentially control ligand affinity (12); our
mutational analysis of this region has shown no relevant
changes in the properties of the purified HCN1CB fragment
and, notably, also of the channel expressed in oocytes. There-
fore, we can conclude that, at least inHCN1, there is no obvious
correlation between the !4-!5 loop and the processes of ligand
binding and/or gating. Because the fully saturated cAMP-
bound form of the HCN tetramer is similar in all isoforms, the
structural differences able to justify the different biochemical
behaviors of HCNs should reside in the apo-form of the pro-
teins. Unfortunately, any attempt to crystallize HCNs in the
unbound state failed. Only the HCN2 structure has been
reported also in the cAMP-free state, but its structure is iden-
tical to the holo-form due to the presence of two bromide ions
located in the cyclic nucleotide binding pocket, one of which
FIGURE 5. Size exclusion chromatography profile of HCNCB mutants. A, elution profile of HCN1CB R538E mutant, in the presence (red lines) and in the
absence (black lines) of 1 mM cAMP. The profile of HCN1CBWT is shown for comparison as a dotted line. Shown are elution profiles of#C-linker HCNCB proteins
(HCN1 (black), HCN2 (blue), and HCN4 (green)) in the absence (B) and in the presence (C) of 1 mM cAMP.
TABLE 3
Effect of mutations in the "4-"5 linker and in "-sheet 5 on the half-
activation voltage of HCN1 (V1/2), measured by two-electrode voltage
clamp in intact oocytes
Channel V1/2 n
HCN1WT %67.5' 0.13 11
G510S %66.5' 0.25 4
S515G/S516N %65.6' 0.23 5
G510S/S515G/S516N %67.9' 0.34 5
M519T %66.5' 0.65 3
R538E %75.9' 0.35 4
HCN2WT %76.5' 0.04 7
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occupied the position equivalent to the phosphate group of
cAMP in the holo-state structure (31). Size exclusion chroma-
tography, sedimentation velocity analytical ultracentrifugation,
and dynamic light scattering were used to analyze the HCN
isoforms in their unbound state in solution.Our results indicate
that in the absence of added cAMP, HCN1CB has a different
oligomerization behavior relative to HCN2CB and HCN4CB.
HCN2CB and HCN4CB were mainly identified as monomers
with only a small amount of dimeric component (Fig. 3,E and F,
solid line). In contrast, HCN1CB exists as a mixture of mono-
mers, dimers, and tetramers (Fig. 3D, solid line). These oligo-
meric states are observed for HCN2CB and HCN4CB only after
adding saturating amounts of cAMP (Fig. 3, D–F, dashed red
line). Thus, one of the main findings is that HCN1CB has a
higher propensity to tetramerize thanHCN2CB andHCN4CB in
the same experimental conditions. Remarkably, this property
clearly pools HCN1CB separately from HCN2CB and HCN4CB
and closely mirrors the grouping established by the in vivo
response to cAMP, with HCN2 and HCN4 linked by the strong
response to cAMP and separated from HCN1.
The analysis of the different HCN species separated by size
exclusion chromatography revealed that HCN1CB contains a
significantly higher amount of endogenous cAMP than
HCN2CB and HCN4CB (molar protein/cAMP ratios of 6, 24,
and 50, respectively) (Table 2) and that almost all endogenous
cAMP is bound to the HCN1CB tetramer, with a cAMP/te-
tramer molar ratio of 2. The correlation between tetrameriza-
tion and cAMP binding is unraveled by analyzing the behavior
of theHCN1CB R538Emutant and the#C-linkerHCN1CB. The
first mutant has an altered cAMP-binding site, resulting in a
reduced affinity for cAMP. The HCN1CB R538E mutant elutes
as a monomer/dimer (Fig. 5A), and tetramerization does not
occur even upon the addition of 1 mM cAMP. The #C-linker
HCN1CBmutant construct has an intact cAMP-binding site but
cannot tetramerize because it is missing the C-linker region.
#C-linkerHCN1CB shows a strong reduction in cAMPcontent,
comparable with those of the other HCN isoforms. We can
conclude that cAMP binding promotes tetramerization and
that in the tetrameric form, cAMP is bound tightly, because the
complex survives extensive dialysis during purification. On the
contrary, cAMP-trapping is not a property of the monomeric/
dimeric HCN isoforms. Our data suggest that cAMP-induced
tetramerization, which is mediated by the C-linker, forces
HCN1CB into a high affinity state that in turn stabilizes the
tetramer. This finding is in line with the reports of state-depen-
dent affinity of HCN channels for their ligand (30, 32) and
agrees with the cyclic allostericmodel proposed forHCN chan-
nels that postulates the coexistence of the protein in resting and
active states with different affinities for the ligand (30, 33, 34).
Furthermore, the presence of a stable tetrameric structure
agrees with the finding that cAMP traps channels in an open
state that kinetically affects the depolarization-dependent
deactivation (35).
As for the possibility of measuring in vitro these two affinity
states, our data show that when probed with the same tech-
nique, the affinities of the three C-terminal fragments appear
similar and do not highlight an obvious difference between
HCN1 and the others. However, as to the absolute values, dif-
ferent techniques yielded very different results.Whereas theKD
andEC50 values obtained by ITCandSPR are in themicromolar
range, we obtained much higher affinities, in the nanomolar
range, by FP. The possibility that the fluorescein-modified ana-
log of cAMP (8-Fluo-cAMP) used in FP experiments has a
higher affinity than cAMP because of its chemical modification
is ruled out by the evidence that 8-Fluo-cAMP and cAMP pro-
duced similar results in ITC when tested on mHCN2 (12). We
can speculate that different techniques might highlight a high
and a low affinity state of the same protein. In this context, the
observation that HCN1CB yielded very poor to absent signals in
SPR and ITC but not in FP may be relevant.
The presence of different cAMP affinities, depending on the
oligomerization state, can be a general property of HCNs, but
HCN1CB differs from HCN2CB and HCN4CB because it
tetramerizes already at basal cAMP concentration and with a
cAMP/tetramer ratio of 2. Thus, in full-length HCN channels,
the CNBD of HCN1, but not that of HCN2 and HCN4, should
exist as tetramers already at basal cAMP concentrations. This
property of HCN1 protein fully explains the right-shifted posi-
tion of the activation curve and the weak response to an
increase of cAMP level in vivo. In regard to the cAMP/tetramer
ratio of 2 found in HCN1CB, half-saturation of the tetramer
appears more likely than half of the tetramers being fully satu-
rated because the second hypothesis would imply that
tetramerization is not mandatorily cAMP-driven. Tetramer
formation with only half of the binding sites being occupied by
cAMP is, on the contrary, consistent with other reports (36)
and would explain other experimental findings, such as the
small additional shift (2–4mV) induced by saturating cAMPon
the already right-shifted activation curve ofHCN1. In this view,
full saturation of the tetramer by high cAMP promotes a resid-
ual conformational change that, in vivo, results in the additional
shift in activation curve. The evidence that a tetramer can form
even if it is not fully saturated by cAMP has a general relevance
for HCN channels that extends beyond the peculiar properties
of HCN1. This is in agreement with the report that in HCN2,
increasing the number of available binding sites from 1 to 4
progressively increases the number of mV in the shift (36).
More recently, Kusch et al. (32) have shown by patch clamp
fluorimetry that only two of the four binding sites in the tetra-
meric HCN2 channel have to be occupied for maximal activa-
tion. Ulens and Siegelbaum (36) have suggested, on the basis of
the stoichiometry of cAMP gating, that a 4-fold symmetric gat-
ing ring forms from a 2-fold symmetric dimer of dimers.
CONCLUSIONS
We showed that the C-terminal domain of HCN1 is different
from those of HCN2 and HCN4 because it partly purifies as a
tetramer, half-saturated with cAMP. Given the well known
effect of cAMP-induced tetramerization in removing the inhi-
bition exerted by this domain on the pore gating, we conclude
that the property of the HCN1 CNBD to accumulate in the
tetrameric state can explain the right-shifted position observed
in HCN1 before the addition of saturating cAMP, whereas its
half-saturation with cAMP can explain the weak response to
saturating cAMP levels. Specifically, we propose the following
model that recapitulates well known properties of HCN chan-
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nels. The C-terminal region exerts a tonic inhibition on the
pore when the C-linker plus CNBD domains are in a non-tetra-
meric form (probably dimers (this paper) (13, 36)). When the
cAMP concentration increases, the C-linker/CNBD region
tetramerizes and releases the inhibition from the pore gate.
This event results in the positive shift of 16–20 mV in the acti-
vation curve of HCN2 and HCN4. In the case of HCN1, a large
fraction of C-linker/CNBD is already tetrameric at basal cAMP
concentrations. Therefore, it does not exert inhibition and
retains the right shifted position of the activation curve. The
addition of cAMP saturates the tetramerization process and
affects the HCN1 activation curve only marginally, reflected in
the modest shift of 2–4 mV.
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Abstract 
We have identified a binding pocket for cyclic nucleotides at the interface 
between the C-linker and the CNBD of HCN4. Occupancy of this pocket by 
the prokaryote second messenger c-di-GMP prevents cAMP-induced activation 
of the channel. Cyclic-di-GMP exerts this inhibitory effect with micromolar 
affinity (k1/2=1.6 µM) on HCN4 and on the If current in sino-atrial node 
myocytes leading to a decrease in heart rate. Virtual high-throughput screening 
identified compound #11, a molecule unrelated to c-di-GMP, that inhibits 
cAMP-induced activation in recombinant and native channels with nanomolar 
affinity (k1/2 = 0.4 uM). Occupancy of the pocket and effect on the current of c-
di-GMP and compound #11 is isoform – specific and was not observed in 
HCN2.  
Our results highlight the presence of an allosteric modulatory pathway in HCN 
channels, indicate a potential drug binding site for heart rate modulation and 
advance understanding of the mechanism of efficacy of cAMP binding in HCN 
channels. 
 
 
 
Key words: HCN, If, cAMP, c-di-GMP, SAN 
 
 Introduction 
Autonomic regulation of the heart rate is shouldered by the funny current (If) 
that responds to changes in cytosolic cAMP concentration by changing its open 
probability, thus affecting the slope of the diastolic depolarization in the 
sinoatrialnode (SAN) action potential.  First shown in 1991 by DiFrancesco 
and Tortora, direct binding of cAMP to the cardiac pacemaker channels was 
explained in its molecular details when the corresponding genes HCN1-4 
(hyperopolarization activated cyclic nucleotide gated) were cloned (Ludwig et 
al. 1998, Santoro et al. 1998) and the cyclic nucleotide binding domain 
(CNBD) of HCN2 eventually crystallized (Zagotta et al. 2003).  As any 
member of the superfamily of Kv channels, functional HCN channels are 
tetrameric. Each monomer contains a transmembrane domain (TMD) 
connected through a 90 amino acid sequence, the C-linker, to the cyclic 
nucleotide binding domain (CNBD). Direct binding of cAMP to the canonical 
binding site in the CNBD, promotes its tetramerization that, in turn, exerts an 
effect on the TMD, i.e. the voltage sensor and the pore. As a result, voltage-
dependent activation is shifted towards less negative potentials and pore 
opening is facilitated. Although cAMP is the most effective ligand, the 
pacemaker current If is also activated by cGMP (DiFrancesco and Tortora, 
1991). Affinity to cGMP was tested so far only for HCN2 (Ludwig et al. 1998, 
Zagotta et al. 2003) but not for HCN4 that is, among the HCN isoforms, the 
most highly (ref rabbit) or the only isoform expressed (mouse) in mammalian 
sinoatrial node (SAN). This work stems from our initial aim to extend 
investigation on cGMP binding to HCN4 and HCN1. To this end we have co-
crystallized the C-linker + CNBD (CL-CNBD) portion of the channels with 
cGMP and solved the structures with a  cGMP molecule inside the canonical 
cyclic nucleotide binding pocket. In the case of HCN4, we found a second 
cGMP molecule bound to a yet unknown binding pocket in the tetramerization 
domain of the protein. This discovery has started our investigation leading to 
the unexpected finding that occupancy of this binding site by c-di-GMP, a 
prokaryote signaling molecule (Jenal and Malone, 2006), inhibits cyclic 
nucleotide regulation of the channel and reduces heart rate in SAN myocytes. 
 
Results 
The If current of the sinoatrial node of the heart is modulated by cGMP, albeit 
with a roughly 40 fold lower sensitivity compared to that for cAMP 
(DiFrancesco and Tortora, 1991).  Although HCN4 is the HCN isoform most 
expressed in the sinoatrial node, so far no available evidence shows that this 
isoform is indeed regulated by cGMP. As a starting point in the study of the 
effect of HCN4 to cGMP, we have co-crystallized the C-linker + CNBD of 
HCN4 with cGMP.  We used HCN4 with cAMP as a searching model 
(Lolicato et al. 2011) and obtained the phase information by molecular 
replacement. The atomic structure was refined at 2.7 Å resolution (Table 
supplementary) and shows a tetrameric assembly of the protomers in which the 
C-linkers provide most of the subunit contacts (Figure 1a). No significant 
differences were observed with the structure of HCN4 with cAMP (Lolicato et 
al. 2011 : the average RMSD of C-! atoms being less than 0.8 A close up view 
of the binding pocket reveals also perfect agreement with that of HCN2 co-
crystallized with cGMP (Zagotta et al. 2003). The cGMP molecule is found in 
the syn configuration, between the beta roll and the C helix.  All the agonist-
protein interactions found in HCN2 are conserved (Table S1), including the 
purine-specific hydrogen bonds with Thr 670 of the beta-roll and with Arg 710 
of the C helix  
To determine the effect of cGMP on HCN4, we expressed the channel in 
HEK293 cells. Inside-out patch clamp recordings from these channels showed 
a behavior very similar to that reported for the native current If. In Figure 1d it 
can be seen that the current recorded in one such patch during 
hyperpolarization to –130 mV increases during perfusion of cGMP at the 
intracellular side due to a positive shift in the activation curve of 11.6 mV 
(Figure 1e). Cyclic GMP induced-shifts were measured for different cGMP 
concentrations and the dose-response relationship is plotted in Figure 1f. Hill-
plot fitting yielded values of 13.2 µM for the half maximal cGMP 
concentration (k1/2) and 0.72 for the Hill coefficient n. Maximal shift was 12 
mV.  For comparison, the equivalent values reported for If are: k1/2 = 7.9 µM, n 
= 0.7 and maximal shift 11 mV (DiFrancesco and Tortora, 1991).  From the 
structural and functional data we conclude that HCN4 is regulated by cGMP 
with modalities closely reflecting those of the native current If, as expected. 
The unexpected finding was a residual electron density at the interface between 
the C-linker and the CNBD in 4 out of 4 protomers of the unit cell. The 
presence of the density is clearly cGMP-specific since co-crystallization with 
cAMP did not produce it (Lolicato et al. 2011). Furthermore, it is also 
concentration-dependent, being more evident at 50 mM than at 5 mM cGMP. 
For all these reasons we refined a cGMP molecule inside the density and the 
result is reported in Figure 2a. A close up view of the binding pocket shows 
that the molecule is found in the syn configuration between helices B’ and C’ 
of the C-linker and  "8 of the " roll. The purine ring interacts exclusively with 
the C-linker, H bonding with Y559 on helix B’ and K562 and F564 on the B’-
C’ linker. The ribose and cyclic phosphate interact with the C linker and the " 
roll, H bonding E566 on helix C’ and Arg 680 on the " sheet 8 Moreover, the 
presence of c-GMP in this novel binding pocket is isoform–specific and it only 
occurs in HCN4 despite the fact that the interacting residues are conserved in 
HCN1 and HCN2. In order to test if the occupancy of this site, presumably 
occurring at high concentrations only, would affect the channel behavior, we 
tested the effect of high cGMP concentrations on HCN4 channel. As shown in 
Figure 2c, at the test voltage of -110 mV addition of 5 mM or 10 mM cGMP 
produces the increase in current, as expected by its binding to the canonical 
binding site in the CNBD.  Anomalously high concentrations of cGMP 
therefore do not exert side effects on the current. Along the same line, we have 
tested if abnormal concentrations of cGMP can affect the effect of cAMP. The 
experiment in Figure 2d shows that this is not the case, as addition of cGMP up 
to 2.5 mM does not change the current recorded in the presence of   5 mM 
cAMP.  In this case, the very high concentration of cAMP was chosen to 
exclude competition between the two agonists for the canomical binding 
pocket in the CNBD  since the k1/2 of HCN4 for cAMP is 1.5 µM (Milanesi et 
al. 2006). 
Thus, the cGMP molecule cannot be considered an alternative modulator of the 
channel, although it was found in the crystal structure. A more detailed 
analysis of the structure revealed that the portion of protein, in which the 
second cGMP was found, is rich of charged residues that create a deeper tunnel 
(compared to the cGMP electron density) able to allocate a larger molecule. 
Ideally a couple of cGMP molecules can fit perfectly on that site, so we tried to 
dock in the new binding pocket a molecule of c-di-GMP (Fig. XX panel a). 
Surprisingly, most of the docking poses overlap substantially with the cGMP 
electron density and the rest of the docked molecule can insert itself through 
the charged amino acids. As an example in Fig. XX panel a is shown a single 
c-di-GMP docking pose. We therefore tested whether c-di-GMP could affect 
the properties of HCN4 expressed in HEK 293 cells. In this case the 
experiments were first performed in whole cell configuration with the agonist 
in the pipette solution. The presence of 100 µM c-di-GMP did not affect the 
currents that appeared indistinguishable from the control. This is shown in 
Figure 3a, displaying exemplary current recordings and the average activation 
curves showing no shift in the open probability of the channel. Surprisingly 
different results were obtained when the experiment was repeated in the 
presence of cAMP (3b). In this case the presence of c-di-GMP completely 
abolished the increase in current induced by cAMP, left-shifting the activation 
curve by 16 mV back to the control position. Panel 3c shows the dose-response 
curve for the effect of c-di-GMP evaluated as the difference in the half 
activation potential (V1/2) recorded in the presence of cAMP. The k1/2 is 1.58 
+/- 0.24 (n=3), while the Hill coefficient n is 1.2.  To test whether c-di-GMP is 
directly acting on the HCN4 channel, we repeated the experiments in inside-
out configuration. Figure 3d shows a typical experiment (n >10):  after the 
control current is recorded at -140 mV (black), addition of 15 µM cAMP  
induces the expected increase in amplitude (red). Further addition of 100 µM 
c-di-GMP to the same solution (green), completely abolishes the effect of 
cAMP on the current amplitude and kinetics. This result is further supported by 
the activation curves reported in panel e that were obtained with a ramp 
protocol from another patch. The presence of c-di-GMP left-shifted the 
activation curve recorded in the presence of c-AMP of about 14 mV, similarly 
to what reported for the whole cell experiments of Panels b.  The very negative 
position of the curves is due to the run down, a known phenomenon occurring 
in inside-out previously described in HCN channels (DiFrancesco et al. 1986). 
These results confirm that c-di-GMP competes with cAMP on the activation of 
HCN4. In order to discriminate between a direct competition with cAMP for 
the canonical cyclic nucleotide binding pocket and an indirect competition that 
would result from the occupancy of the second binding pocket highlighted in 
the crystal, we have increased the cAMP concentration up to 1mM in order to 
compete out the c-di-GMP from the canonical pocket. Since we have not seen 
any change (panel f), we concluded that c-di-GMP counteracts the effect of 
cAMP by binding to another site on the channel that must be downstream of 
the cAMP binding and that we have presumably identified on the crystal 
structure as being at the interface between the C-linker and the CNBD. 
As additional proof, the c-di-GMP molecule was in silico docked on the 
canonical binding site of the human HCN4 structure previously published 
using the docking software eHiTS (Zsoldos et al., 2006, Zsoldos et al., 2007) , 
removing the cAMP from that site. Docking attempts showed that the c-di-
GMP molecule was too large to be accommodated in the cAMP binding 
pocket.   
Several attempts were performed to co-crystallize the HCN4 protein with the 
c-di-GMP molecule in the allosteric pocket. The presence of c-di-GMP clearly 
disturbs the crystals that diffracted at quite low resolution and always above 6 
Å. We could nonetheless solve the structure of the protein in the presence of c-
di-AMP at a resolution of 3.7 Å.  
In this case we could solve the molecule inside the density even though we 
could not see the position of the side chains in the amino acids surrounding the 
pocket.  
Interestingly, we found the c-di-AMP bound in only two monomers of sixteen 
(four tetramers) in the asymmetric unit, and there with occupancy <1. This 
finding allowed the protein to diffract at a reasonable resolution, indicating that 
the protein was only partially disturbed by the presence of the molecule. On 
the contrary what happened with the c-di-GMP. 
This achievement confirms that cyclic dinucleotides can occupy the allosteric 
pocket, but worth noting that both the cGMP (gray electron density) and the 
docked c-di-GMP (blue sticks) assume a different orientation compared with 
the crystallized c-di-AMP (red sticks, vedi figure sovrapposte) indicating 
possible different interactions with the protein. 
As the fig. sovrapposte shows, the crystallized c-di-AMP protrudes outside the 
“hot spot” of the allosteric binding pocket. Potentially, this lack of contacts 
with the protein is significant for the binding affinity and allowed the tetramer 
to pack properly. 
The effect of c-di-AMP was therefore tested on HCN4 current by adding 100 
µM of the ligand in the pipette in the presence of cAMP. As shown by the 
curves reported in Figure 4a, also this molecule prevents cAMP-induced 
activation of the current.  
Looking at the three docking poses of c-di-GMP shown in Figure 4b the amino 
acid E566 is the only one that interacts with all of them, appearing as a 
relevant residue for binding. As predicted, mutation E556K in hHCN4, 
removes the response to c-di-GMP, as shown in Figure 4, panel b.  
The evidence that binding of a small molecule to this site induces such a 
drastic and relevant effect on the HCN channel current, prompted us to screen 
for unrelated molecules by using the in silico virtual high-throughput screening 
program eHiTS. More than 300000 molecules from the Maybridge 
(http://www.maybridge.com/portal/alias__Rainbow/lang__en/tabID__146/Des
ktopDefault.aspx), Chembridge (http://www.hit2lead.com/)  and Peakdale 
Molecular Scientific (http://www.peakdale.co.uk/products/screening-
compounds.html) screening libraries were screened. The top 1000 compounds 
were further examined using the de novo design software SPROUT (Gillet et 
al., 1995, Gillet et al., 1994, Law et al., 2003, Zsoldos et al., 2003)  and the 
most promising scaffold chosen according to synthetic accessibility and 
desirable solubility properties as well as predicted binding affinity. Eleven of 
the most structurally diverse compounds were selected for testing on HCN4. 
Out of 11, the best effect was found with the compound N'-biphenyl-2-yl-N-[1-
(3-cyanobenzyl)piperidin-4-yl]-N-(pyridin-3-ylmethyl)urea (IUPAC name, 
hereafter called compound 11) . Figure 5 shows in panel a the molecule inside 
the allosteric pocket and, in a close up view, the main protein-ligand 
interactions. When tested on the channel by patch clamp experiments, this 
molecule was able to abolish the effect of cAMP in a dose-dependent way. 
Panel b shows an exemplary experiment performed in whole cell in which the 
presence of 100 µM compound 11 in the pipette was able to abolish the 
increase in current induced by the addition in the bath of the membrane 
permeant 8-Br-cAMP. Panel c shows the average activation curves recorded 
with the mix of three molecules 5, 8 and 11 (out of 11 selected by docking), 
and with the single molecules, to show that only compound 11 was found 
active. The dose-response curve of compound n.11 evaluated on the cAMP-
induced shift (panel d) highlights a k1/2 of  0.42 +/- 0.11 µM, higher than that 
of c-di-GMP. This result shows that the pocket identified in this work can be 
considered a potential drug binding target, inasmuch unrelated molecules, 
selected in totally independent ways, induce the effect on the current upon 
micromolar or submicromolar binding.  
Thinking along this line, another property that appears appealing for a potential 
drug binding site is isoform-specificity.  Indeed, as previously mentioned, the 
electron density found in the presence of cGMP, was more evident in the 
structure of HCN4 than in other HCN isoforms, when crystallized in the same 
experimental conditions. We have therefore determined the effect of c-di-GMP 
on the current of human HCN2 in HEK 293 cells. Figure 6 panels a and b show 
respectively that 100 µM c-di-GMP and 200 µM compound 11 do not revert 
the action of cAMP thus confirming that this binding site is isoform-specific. 
The next step was to verify if the native current If in the cardiac sinoatrial node, 
was similarly affected by the two molecules, c-di-GMP and compound n.11. It 
is known that HCN4 is the major (rabbit) and in some cases the only (mouse) 
molecular determinant of the native channel expressed in the pacemaker region 
of the mammalian heart. To this end we acutely isolated sinoatrial node (SAN) 
myocytes from mouse heart and recorded the native current If in whole cell 
configuration. Figure 7a shows exemplary currents recorded in SAN myocytes 
in control solution and in the presence of 10 µM cAMP.  The addition of c-di-
GMP or compound 11 is able to block the effect of cAMP on the current. This 
is clearly shown by the activation curve of panel b, showing the reversion of 
the shift in the activation curve to the control position induced by c-di-GMP or 
compound 11. Last, we tested if the addition of compound n.11 or c-di-GMP 
was able to affect the heart rate.  
  
Discussion 
 
1-interest from a molecular biophysics point of view: Novel binding pocket 
identifies a region of the protein that controls the efficacy of cAMP. We can 
mention here that all mutants in the pocket (so far we have tested 3) are 
affected either in the response to cAMP and/or in the basal position of the 
activation curve.  
If with the flash exp we can show the relationship to the affinity in the CNBD, 
we will stress the point that this is a hub that transducer the voltage sensor 
movement in the TMD into a change in affinity in the CNBD during activation 
and vice-versa, transduces the binding of cAMP into a facilitated opening of 
the pore. 
Evidences that this is a hub for cAMP effect: the mutant F564T is already 
shifted and does not respond to cAMP. 
We have previously highlighted differences in the biochemical properties of 
the three C-terminal proteins, in particular in the dynamics of cAMP–induced 
tetramerization (Lolicato et al). Therefore, differential binding of cGMP in a 
position that seems to be relevant for the tetramerization of the proteins, does 
not come totally unexpected. 
 
2- interest for drug design: this is a potential binding site for drugs because 
binding of molecules in this pocket controls the autonomic control on the heart 
rate, an important aspect of therapy during heart failure; it is isoform-specific 
excluding side effects on HCN2 ( HCN1 is not important because cAMP-
induced shift does not occur in HCN1); it acts at nanomolar affinity;  
 
3-interest for c-di-GMP:  
Cyclic di-(3’:5’)- guanosine monophosphate (c-di-GMP) is a prokaryotic 
second messenger, recently found also in lower eukaryotes (Chen and Schaap, 
2012). As a second messenger, it regulates bacteria motility and biofilm 
formation (Jenal and Malone, 2006). Cyclic-di-GMP induces a potent immune 
response in infected cells and for this role it is frequently used as a co-adjuvant 
in vaccinations (Hu et al.,2009). Recently, it was shown to induce a type I 
interferon response that depends on its direct binding to STING (stimulator of 
interferon genes) (Yin, Q. et al. 2012, Huang et al. 2012), a ER-localized 
transmembrane receptor that links cytosolic detection of bacterial DNA to 
interferon synthesis.  
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 Figure legends 
 
Figure 1 
(a) Tetrameric assembly of the HCN4 C-linker+CNBD in the presence of 
cGMP. 
(b) Close-up view of one monomer with the cGMP molecule in the canonical 
binding site. 
(c) Electron density map (top) and polar contact (bottom) of a molecule of 
cGMP in the canonical binding pocket. 
(d) Example trace current recording of HCN4 channel in the absence (black) 
and in the presence (red) of the ligand cGMP. 
(e)  Activation curves of the apo (black) and cGMP-bound (red) HCN4 
channel. 
(f) Titration curve of cGMP recorded onto HCN4 channels. 
 
Figure 2 
 
(a) Cartoon representation of a monomer of the crystallized HCN4 in the 
presence of cGMP in both the canonical binding pocket and in the 
new additional regulation site. The electron density (gray net) of the 
cGMP in the new site is also represented. 
(b) Polar contacts occurring between the cGMP in the new binding site 
and its coordination aminoacids of HCN4. 
(c,d) High concentrations of cGMP do not reduce the effect of cAMP. We 
haveused 5 mM cAMP to exclude competition on the canomical binding 
pocket.  
 
 
Figure XX 
>(a) 
Close-up view of the C-linker region of HCN4. 
The gray trace is the electron density, countered at 1.5 sigma, of the cGMP 
crystallized in the allosteric binding pocket. 
The blue sticks represent a single pose of the docked c-di-GMP, with 
substantially overlapping region with the cGMP electron density. 
The side chains of charged aminoacids are, also, represented, highlighting a 
"charged tunnel" able to allocate a larger molecule. 
 
 
(b) 
Structure superposition of HCN4 CNBD in the presence of c-di-AMP (red 
sticks and cyan backbone) and the docked c-di-GMP (blue sticks). The green 
backbone is of the crystal structure of HCN4 in the presence of cGMP in the 
allosteric pocket (gray grid countered at 1.5 sigma). 
 
 
Figure 3 
 
(a) Example trace record (top) and activation curves (bottom) of 
HCN4 channels in the presence (red) and in the absence (black) of the 
molecule c-di-GMP. 
(b) Same as (a), but also in the presence of saturating amount 
(15uM) of cAMP. 
(c) Dose-response curve of the c-di-GMP 
(d) Inside-out experiments on HCN4 currents in the presence of c-
di-GMP (green, together with cAMP). The control curve is 
represented in black, while the control in the presence of only cAMP 
is represented in red. 
(e) Ramp protocol of HCN4 in the presence of cAMP alone (black) 
or in the presence of c-di-GMP (red). 
(f) Competition experiments conducted with 1mM cAMP (blue track). 
Experiments performed as same as (d). 
 
 
Figure 4 
 
(a) Crystal structure of HCN4 in the presence of a molecule of c-di-
AMP (green cartoons) flanked by a sketch representation of the 
molecule (left) and the effect of the molecule on the channel behavior 
in the presence of cAMP (right). 
(b) Same as (a), except for the cartoon representation: here are 
presented three docking poses (cyan, magenta and orange) of the 
molecule c-di-GMP on the crystal structure of HCN4. 
  
Figure 5 
 
(a) Cartoon representation of HCN4 crystal structure with a 
molecule of compound 11 docked in the new binding pocket (left). 
The aminoacids involved in the stabilization of the molecule in the 
pocket are shown in the right panel. 
(b) Effect of the selected compounds on HCN4 current. The 
compound 11 was the only one able to give a measurable effect on the 
channel. The dose-response curve is represented in the right figure. 
 
 
 
Figure 6 
 
Effect of c-di-GMP (a) and the compound 11 (b) on HCN2 channels. 
Experiments performed in whole-cell configuration. 
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 Methods 
 
Electrophysiology 
Wild-type HCN4 channel complementary DNA (cloned in pcDNA1.1, kindly 
provided by Prof. DiFrancesco D.) was transfected for transient functional 
expression into HEK293 cells with a plasmid containing green fluorescent 
protein, as described previously. From one to five days after transfection, the 
cells were dispersed by trypsin and plated on 35-mm plastic petri dishes. A 
dish was placed under the stage of an inverted micro- scope, and GFP-
expressing cells were selected for patch-clamp analysis at room temperature 
(25 to 26?C). The pipettes used in the whole-cell patch-clamp experiment 
contained 10 mM sodium chloride, 130 mM potassium chloride, 1 mM egtazic 
acid (EGTA), 0.5 mM magnesium chloride, 2 mM ATP (sodium salt), 0.1 mM 
guanosine triphosphate (sodium salt), 5 mM phosphocreatine, and 5 mM 
HEPES potassium hydroxide buffer (pH 7.2). The control extra- cellular 
solution in whole-cell experiments contained 110 mM sodium chloride, 30 
mM potassium chloride, 1.8 mM calcium chloride, 0.5 mM magnesium 
chloride, and 5 mM HEPES sodium hydroxide buffer (pH 7.4); 1 mM barium 
chloride, 2 mM manganese chloride, 100 !M nickel chlo- ride, and 20 !M 
nifedipine were added to improve dissection of the pacemaker current. The 
pipettes used in inside-out macropatch experiments contained 70 mM sodium 
chloride, 70 mM potassium chloride, 1.8 mM calcium chloride, 1 mM 
magnesium chloride, 1 mM barium chloride, 2 mM manganese chloride, and 5 
mM HEPES  sodium hydroxide buffer (pH 7.4); bath solution contains 130 
mM potassium aspartate, 10 mM sodium chlo- ride, 2 mM calcium chloride, 5 
mM EGTA potassium hydroxide, and 10 mM HEPES potassium hydroxide 
buffer (pH 7.2). (Milanesi et al. 2006) 
 
 
Virtual high-throughput screening using eHiTS 
The electronic high-throughput screening program eHiTS (Zsoldos et al., 2006, 
Zsoldos et al., 2007) utilises an exhaustive systematic search algorithm that 
considers all docking poses that lack severe steric clashes with the protein. The 
system employs a unique graph matching algorithms and dock tables which are 
stored in SQL databases. Unlike DOCK or FlexX 
(http://www.biosolveit.de/FlexX-C/), eHiTS does not use an incremental 
construction method but instead attempts to find the global optimum by 
enumerating combinations of independent fragment dockings. 
The eHiTS software has a novel flexible docking ligand method that 
exhaustively produces all ligand poses that avoid severe steric clashes between 
the protein receptor and the ligand. In the first instance, the binding pocket is 
defined by a steric grid which divides regions into separate pockets and 
identifying all possible interaction sites. The ligand is divided into rigid 
fragments and connecting flexible chains. Each fragment is wrapped into a 
polyhedron shape with chemical properties assigned to the vertices of the 
polyhedron. All rigid fragments are docked to every possible place in the 
newly identified binding site and scored for predicted binding affinity. 
 Initially, a simple and fast chemical flag based statistical scoring function is 
used during the rigid fragment-docking and pose-matching phases. This 
function is not too sensitive to small variations in the interaction geometry, 
interaction distance and hydrogen-bonding angle. 
All ring systems are considered rigid and their conformation is preserved as 
given in the input. Therefore, it is desirable to use multiple ring conformers 
(e.g. chair, boat and twist boat for a cyclohexane) for complete conformational 
sampling. These can be generated using a conformer generation program such 
as Corina (Schwab, 2010).  An exhaustive matching of compatible rigid 
fragment pose sets is performed to yield complete structures. Typically, the 
program evaluates several million mappings of the rigid fragment polyhedra to 
cavity polyhedra. The reconstructed solutions define a rough binding pose 
which is then refined using a local energy minimisation in the targeted site of 
the protein receptor. A more sensitive, empirical-scoring function is used 
during the final local energy minimization phase. This scoring function has 
smooth curves representing the distance and angle dependency of the 
interactions while supporting efficient gradient-based optimization.  
The final resulting poses are evaluated using a third, more time consuming 
scoring function that combines both statistical and empirical components, plus 
additional grid based geometrical terms as well as entropy loss estimation and 
another novel scoring element based on the coverage of receptor surface area. 
This final scoring function attempts to estimate the binding free energy more 
accurately. The result of the final accurate scoring is used to rank the generated 
solutions (Zsoldos et al., 2007). 
Using the high-throughput screening mode within the program (version 9.0), 
three compound libraries containing a total of 300 000 commercially available 
compounds from Maybridge(http://www.maybridge.com), 
Chembridge(http://www.chembridge.com) and 
Peakdale(http://www.peakdale.co.uk) were screened against the new x-ray 
crystal structure of HCN4.  
From the library of commercially available molecules, 1000 compounds were 
selected for further evaluation and consensus scoring using the de novo design 
program SPROUT (Gillet et al., 1995, Gillet et al., 1994, Law et al., 2003, 
Zsoldos et al., 2003). These 1000 compounds were selected based on their 
predicted binding to the protein as calculated using the eHiTS scoring 
algorithm. From this set, 11 molecules were selected for purchase. These 11 
compounds were chosen based upon their predicted binding affinity to the 
protein as determined using the eHiTS and SPROUT scoring functions and 
also their predicted binding pose, as visualised using the SPROUT protein 
boundary surface representation.  
High-resolution mass spectroscopy was used to confirm the integrity of the 
purchased compounds. 
 
 
Protein preparation 
The cDNA fragment comprised the C-linker (CL) and CNBD region of human 
HCN4 and encoded residues 521-723, were cloned into a modified pET-24b,  
transformed into E. coli Rosetta strain and overexpressed as previously 
described (Lolicato et al. 2011). Briefly, cells were grown at 37 °C in LB broth 
to 0.6 OD600 and induced with 0.4 mM isopropyl-1-thio"-D-galactopyranoside 
(IPTG) O.N. at 20 °C. The cells were collected by centrifugation and 
resuspended in ice-cold lysis buffer (30 mM Hepes pH 7.4, 500 mM NaCl, 
10% glycerol, 1 mM "-mercaptoethanol) with the addition of 10 µg/ml DNAse, 
0.25 mg/ml lysozyme, and inhibitor cocktail. The cells were sonicated on ice 
12 x 20 sec and the lysate cleared by centrifugation. The proteins were purified 
by affinity chromatography on Ni2+-NTA and eluted in lysis buffer plus 300 
mM imidazole. The tag was removed by HRV3C cleavage O.N. at 4 °C. The 
cleavage reaction was further purified by amylose resin (New England 
Biolabs) followed by a size-exclusion chromatography onto a HiLoad 16/60 
Superdex 200 column (GE Healthcare). 
 
Crystallization 
Crystallization trials were set up in 96-well sitting drop plates (Greiner) using 
the Orxy 8.0 crystallization robot (Douglas Instruments) and stored at 4 °C. 
Crystals were further optimized in 24-well hanging-drop plates.  
Crystals of the HCN4-cGMP complex (protein concentration 7-13mg/ml, 5-50 
mM cGMP) were grown by vapor-diffusion using as a precipitant solution 10-
15% PEG3350, 200mM sodium acetate buffer, pH 5.0 and 200mM 
Ammonium phosphate.  
Crystals were cryoprotected with the same solution plus 5% PEG3350 and 
25% glycerol. 
A full data set was collected to 2.7 Å resolution (IDxx beamline, ESRF, 
Grenoble, France).  
Crystals of the HCN4-cGMP-cidiGMP complex (protein concentration 
10mg/ml, 5mM cAMP and 5-50mM c-di-GMP) were grown by vapor-
diffusion using as a precipitant solution 200mM K/Na tartrate (with/without 
100mM MES, pH=6.5 or 100mM Tris-Cl, pH=7.5). 15-30 crystals were tested 
for diffraction but none of them reached a resolution better then 6.0 Å, so no 
dataset were collected. (IDxx beamline, ESRF, Grenoble, France and XALOC 
beamline, ALBA, Barcelona).  
Moreover soaking experiments with 50mM c-di-GMP (biolog.de) on crystal 
grown in the presence of cGMP were performed. Crystals were tested for 
diffraction (XALOC beamline, ALBA, Barcelona, Spain), but no dataset were 
collected due to poor diffraction. 
Crystals were cryoprotected with the same grow solution plus 5% precipitant 
and 25% glycerol or 25% PEG400. 
Crystals of the HCN4-cGMP-cidiAMP complex were obtained by soaking (48 
hours) of HCN4-cGMP protein crystals on a cryo-solution containing 20mM c-
di-AMP (Biolog.de), 15% PEG3350, 200mM Ammonium phosphate, 200mM 
Sodium acetate, pH=5.0 and 25% Glycerol. 
Crystals were directly frozen in liquid nitrogen. 
A full data set was collected to 3.7 Å resolution (XALOC beamline, ALBA, 
Barcelona, Spain).  
Raw data were processed with Mosflm (Battye et al. 2011) and Scala  and the 
structures were solved by molecular replacement using the program MolRep 
(Vagin and Isupov, 2001) (HCN4-cGMP) or Phaser (HCN4-cGMP-cdiAMP) 
(McCoy et al. 2007). The crystal structure of human HCN4 in complex with 
cAMP (Lolicato et al. 2011) (PDB entry-code 3U11) was used as search model. 
To avoid model bias, the bound-cAMP was removed from the search model. 
Several cycles of manual rebuilding, using the program COOT (Emsley and 
Cowtan, 2004), and refinement, using the program REFMAC5 (Murshudov et 
al. 2011 and Murshudov et al. 1997) (rigid body and restrained refinement), 
were carried out to improve the electron density map. 
For the complex with c-di-AMP molecule, ligand restraints were generated by 
the program JLigand (Lebedev et al. 2012) and additional cycles of refinement 
with REFMAC5 using TLS restraints together with additional restraints 
generated by PROSMART (Nicholls et al. 2012) were used to improve the 
final model. 
 
The final R-factor/R-free are 20/25 . The programs Procheck (Laskowski  et al. 
1993) was used to assess protein stereochemical quality. The program PISA 
(Krissinel and Henrick, 2007) was used to identify and analyze the quaternary 
assemblies. Atomic coordinates and structure factors have been deposited with 
the Protein Data Bank, with entry codes XXXX and YYYY for HCN4-cGMP, 
and HCN4-cGMP-cdiAMP, respectively. 
 
 
 
